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Synthetic poly(ethylene glycol) (PEG)-based hydrogels have been widely used as a 
highly valuable class of biomaterials for various biomedical applications due to their 
inherent biocompatibility, biochemical inertness and ease of meeting specific 
requirements through functional tailoring. The overall goal of this thesis is to design, 
develop and evaluate the application of synthetic PEG-based hydrogels in two different 
biomedical applications: tissue engineering and antimicrobial therapeutics. 
 
In tissue engineering, we hypothesized that genetic manipulations of human 
mesenchymal stem cells (hMSCs) in a nanostructured hydrogel microenvironment will 
provide an effective approach to improve cell delivery for tissue engineering.  
 
To test our hypothesis, we explored two specific aims: 
Aim 1: Synthesize and characterize injectable PEG hydrogels with micellar 
nanostructures incorporated. Here we described the rationale of incorporating micellar 
particles into PEG-based hydrogels with key features of tuning the physical properties of 
the hydrogels such as swelling ratio, porosity and degradability. We successfully 
demonstrated that the physical properties of the hydrogels could be tuned predictably and 
thus enabled the subsequent study of biological interaction between the PEG-based 
hydrogel scaffold and encapsulated cells. 
 
viii 
Aim 2: Evaluate cell viability and gene transfection efficiency of hMSCs 
encapsulated in the nanostructured hydrogels. Here we further evaluated the hydrogel 
scaffold for both cell survival and gene transfection. We demonstrated that our synthetic 
bolaamphiphile was superior to poly(ethylenimine) (PEI) as non-viral gene carrier and 
hydrogels with 20% micelle content provided the optimal microenvironment for both cell 
survival and gene transfection. Therefore, incorporating micelles into hydrogels is a good 
strategy to control cellular behavior in a three dimensional hydrogel environment for 
tissue engineering. 
 
For antimicrobial therapeutics, we hypothesized that hydrogels with cationic polymers 
incorporated provide an excellent formulation for clinical use in eliminating various 
microorganisms and biofilms.  
 
To test our hypothesis, we explored three specific aims: 
Aim 1: Synthesize and characterize cationic polymers for the formation of 
stereocomplex PEG hydrogels with supramolecular structures. Here we first 
described particle size and toxicity of the three cationic polymers followed by the 
evaluation of physical properties of the cationic polymer incorporated hydrogel including 
stereocomplex formation, stiffness and supramolecular structures. It was demonstrated 
that polymer with optimal hydrophobic/hydrophilic balance was the least toxic and 
cationic polymer containing hydrogel formed through stereocomplexation with shear-
thing property and ribbon-like supramolecular structure were observed. 
 
ix 
Aim 2: Evaluate the antimicrobial and antibiofilm activities of the hydrogel with 
cationic polymer incorporated in vitro. Here we evaluated the antimicrobial and 
antibiofilm activities of the hydrogel with different amount of cationic polymer 
incorporated in vitro. We showed that these hydrogels exhibited broad spectrum 
antimicrobial activities against both Gram-positive and Gram-negative bacteria, fungus 
and various clinically isolated drug-resistant pathogens. Moreover, they were capable of 
dispersing biofilms formed by S. aureus, methicillin resistant S. aureus, E. coli and C. 
candida. The mechanism of antimicrobial and antibiofilm action was found to be through 
the physical disruption of the bacterial cell membrane. 
 
Aim 3: Investigate the in vivo activity of our hydrogel using the fungal keratitis 
animal model. Here we tested the antibiofilm activity of the hydrogel on the fungal 
keratitis animal model in vivo. It was demonstrated that our hydrogels were comparable 
or superior to commercially available antibiotics Amphotericin B, evidenced by the 
significant decrease in fungal recovery and hyphae invasion without any display of 
toxicity in healthy eyes. Therefore, these cationic hydrogels showed great potential for 
clinic use in eliminating various microorganisms and biofilm infections. 
 
In conclusion, the findings of this thesis supported the hypothesis specified in each 
application and well-defined synthetic PEG-based hydrogels served as a promising 
platform in meeting the specific requirements in our intended applications in tissue 
engineering and antimicrobial therapeutics. 
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CHAPTER 1. INTRODUCTION 
1.1 What are hydrogels? 
Hydrogels are, by definition, crosslinked polymeric networks with the ability to hold 
water as the continuous phase in the space between the polymeric chains. Water holding 
capacity of the hydrogel is dependent on the presence of hydrophilic groups such as 
amide (-CONH), hydroxyl (-OH) and carboxylic (-COOH) group found in the polymer 
backbone or as side chains. The integrity of hydrogels in water is maintained mainly due 
to the molecular interactions, including covalent and non-covalent forces between 
individual polymeric components present in the three dimensional network. 
 
Polymeric hydrogels may be classified in different ways according to the nature of 
materials (natural vs synthetic), preparation methods (physical vs chemical) and 
biodegradability. The diverse material sources and preparation methods have significant 
implications on the physical properties of the hydrogels, such as three dimensional 
network, controllable mechanical properties, biodegradability and biocompatibility. The 
versatility of hydrogels has been demonstrated in a wide range of applications as food 
additives [1], pharmaceutics [2, 3] and environmental applications [4]. Due to their 
biocompatibility and the ease of tuning their physical properties, researchers have 
intensively exploited hydrogels for biomedical applications, including drug and cell 
delivery [5], wound healing [6] and tissue engineering [7] over the last 2 decades. 
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The aim of this chapter is to introduce readers to the nature of hydrogel materials, the 
preparation of hydrogels, their physical properties and finally their application in specific 
biomedical applications. 
 
1.2 Materials of hydrogels  
Polymer hydrogels for biomedical applications can be of either natural, synthetic origin 
or a combination of these two types of material. For example, alginate and chitosan are 
the two most widely used natural hydrogel materials which have gained substantial 
importance over the years [8, 9]. Collagen, gelatin and hyaluronic acid (HA) are natural 
components of extracellular matrix and have been successfully used as hydrogels for 
stem cell differentiation [5, 10, 11]. These natural polymers closely mimic targeted tissue 
structure because they are either components of or similar to the targeted living body in 
various macromolecular properties. Moreover, they interact with the targeted tissue in a 
favorable manner by presenting receptor-binding ligands and cell-triggered enzymatic 
degradation. Despite these advantages, it is difficult to tailor mechanical and 
degradability of these natural hydrogels in order to meet different requirement of specific 
applications. Furthermore, usage of these natural materials has been seriously restricted 
due to the potential risk of immunological reactions and pathogen transmission [12].  
 
Apart from natural polymers, synthetic polymers provide an alternative and effective way 
for hydrogel formation and their broad applications. Hydrogels prepared from synthetic 
polymers differ in their properties due to various chemical structures, synthesis strategy 
and controllable hydrogel preparation techniques. In synthetic hydrogels, gel physical 
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properties and biological interactions between the hydrogel and living body are readily 
controlled, and therefore have significant advantages over natural polymers.  For example, 
Benoit et al have successfully manipulated hydrogel degradation rate by changing the 
content of degradable macromere poly(lactic acid)-b-poly(ethylene glycol)-b-poly(lactic 
acid) endcapped with methacrylate groups (PEG-LA-DM) in the hydrogel to enhance 
osteoblast function and mineralized tissue formation [13]. Liu et al has prepared arginine-
glycine-aspartic (RGD) peptide-containing hydrogels with tunable physicochemical and 
biological performance by varying fabrication temperatures. Specifically, increasing 
RGD concentration significantly enhanced cell attachment and proliferation in the 
hydrogel scaffold [14].  
 
Many synthetic polymers, such as poly (D,L-lactic-co-glycolic acid) (PLGA) [15], poly 
(hydroxyethyl methacrylate (pHEMA) [16] and poly (ethylene glycol) (PEG) [17, 18], 
have been used in the formulation of hydrogels. Among these materials, poly (ethylene 
glycol) (PEG) hydrogel is one of the most widely used materials in biomedical 
applications due to their high compatibility, nontoxicity, low immunogenicity and highly 
water-swollen network. Functional groups, such as acrylate and methacrylate can be 
easily incorporated with PEG to form hydrogel network in the presence of appropriate 
photoinitiator or crosslinker. For instance, Bryant et al have prepared a poly(ethylene 
oxide) dimethacrylate hydrogel with varying thickness using UV photoinitiator for 
cartilage regeneration [19, 20]. Kim and team have mixed copolymer methacrylic acid 
(MMA) with PEG-PEGMA using tetra (ethylene glycol) dimethacrylate as crosslinker for 
insulin release [21]. More importantly, significant progress has been made to improve 
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cell-hydrogel interactions through the addition of cell adhesion peptides and 
enzymatically degradable entities. For example, the addition of RGD peptides as 
adhesive points has been utilized to promote stem cell proliferation in PEG hydrogels 
[22]. Lutolf et al has synthesized enzymatically degradable PEG hydrogel crosslinked by 
cysteine-containing matrix metalloprotease (MMP) oligopeptides for various applications 
[23, 24].  Therefore, PEG hydrogels with tunable physical properties and desirable 
biological interaction with the living body serve as superior hydrogel materials for 
various biomedical applications. 
 
1.3 Preparation methods of PEG hydrogels 
PEG hydrogels are commonly prepared by crosslinking either in a physical or chemical 
way. According to Hoffman, chemical hydrogels are permanent gels stabilized by 
covalently crosslinked networks [25], whereas physically crosslinked hydrogels do not 
rely on covalent bond formation and are generally formed through physical interactions, 
such as hydrogen bonding, molecular entanglement and ionic interaction. For example, 
Percec et al has blended hydrophobic aromatic poly(ether sulfone) and hydrophilic 
Poly(2-ethyl-2-oxazoline) polymers to form a physical hydrogel via hydrogen bonding 
[26]. Aqueous PVA solution turned into a highly elastic physical hydrogel in the process 
of freeze-and-thaw due to the formation of PVA crystalline, which acts as physical 
crosslinking points in the network [27]. Although these physically crosslinked hydrogels 
have been widely used in various medical applications, [10, 28], one significant 
limitation of these hydrogels is their poor mechanical strength attributed to the weak 
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physical interactions. It is also difficult to obtain stable physically crosslinked hydrogel 
with tunable degradation rates.  
 
Chemical crosslinked hydrogels are generally obtained via photopolymerization, click 
chemistry and Michael addition polymerization. Although the resulted chemically 
crosslinked hydrogels are more robust and stable than physical hydrogels, an important 
concern about chemically crosslinked hydrogels is the potential cytotoxicity caused 
during the hydrogel formation. In a typical photopolymerization reaction, acrylate 
functionalized PEG monomer was polymerized using UV and visible light [29, 30].  One 
major limitation of this method is the poorly controlled structure due to radical chemistry. 
On the other hand, the copper-mediated 1,3-cycloaddition reaction of an azide with an 
ethynyl (known as Click Chemistry) [31] represents a class of reaction, which is fast and 
efficient, and allows for the fabrication of  hydrogels with improved mechanical 
properties as compared to those synthesized through photopolymerization. However, it 
relies on copper ion as catalyst, which is cytotoxic when used in biomedical applications.  
 
In contrast, Michael addition chemistry, which was first exploited by Hubbell and 
coworkers [32], can be used to form PEG hydrogels under physiological conditions. In a 
typical reaction, macromers containing terminal thiol groups are reacted with multi-arm 
PEG macromers with acrylate or vinyl sulfone end groups to form stable thioether 
linkages through michael-type conjugate addition (Scheme 1). It does not require any 
initiator or catalyst in the reaction. Various Michael addition hydrogels have been 
reported, including hydrogels formed from PEG tetra-acrylate and thiol-modified dextran 
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[33], PEG diacrylate with thiol-modified hyaluronan [34]. Moreover, as this reaction 
proceeds under physiological conditions, thiol groups in the proteins and other 
biomolecules can participate and provide a convenient way to incorporate bioactive 
substance into the hydrogels. Thus, Michael addition serves as a promising approach to 
synthesize injectable hydrogels and have been widely used for cell and gene delivery [35] 
and tissue engineering [23]. In short, it is crucial to choose specific preparation 
techniques according to the intended end-applications.  
 
Figure 1.1 Synthesis scheme for the stepwise copolymerization of biomolecules 
containing free thiols on Cys residues with end-functionalized PEG macromers bearing 




1.4 Physical properties of hydrogels 
Since hydrogels can be used in various biomedical applications which require different 
properties, it is important to characterize the mechanical properties of hydrogels. The 
strength of the hydrogel can be tuned by incorporating crosslinker, comonomers and 
increasing degree of crosslinking. However, there is an optimum mechanical strength for 
different applications. For example, soft hydrogels are preferred for neural regeneration 
[37] whereas bone tissue engineering requires hydrogel scaffolds to be more robust [38]. 
Too high a mechanical strength may lead to brittleness and less elasticity, the latter of 
which is important to provide flexibility to the hydrogel and facilitate the interaction 
between the hydrogel and target tissue. Thus it is important to strike a balance between 
mechanical strength and flexibility for the appropriate use of hydrogels.  
 
Apart from mechanical strength of the hydrogels, a networked structure also plays a key 
role in biomedical hydrogel applications. These networks have a three dimensional 
structure and are crosslinked in a well-defined order. Hydrogel swelling generally results 
in a reduction in mechanical strength. Porosity of the hydrogels in return affects the 
hydrogel swelling and mechanical strength. These parameters are highly intertwined and 
an optimal balance between them is always essential for specific hydrogel application.  
 
Shear thinning is another important property of hydrogel for biomedical applications. For 
example, injectability is a major requirement for minimal invasive surgery. Injectable 
hydrogel can be easily mixed with various therapeutics and cells before crosslinking and 
applied through a syringe to readily take the specific shape of target sites, providing 
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excellent interface between the hydrogel and tissue [39]. Moreover, remodelability is also 
desirable for topical applications [40].  
 
Since the interaction between the hydrogel and targeted tissue is on both macroscopic 
mechanical and microscopic biological level, it is of great importance of study the 
degradability and biocompatibility of the hydrogels. The desired degradability of the 
hydrogel depends on specific applications and it is important to design and control 
degradation rate according to the unique requirement. There are three main degradation 
mechanisms: hydrolysis [41], enzymatic cleavage [42] and dissolution [43]. Most of the 
synthetic hydrogels adopt a hydrolysis degradation of ester bond at a constant rate [44, 
45]. Moreover, hydrogels need to be biocompatible with the targeted tissue in order to be 
used safely. All polymers applied for biomedical applications and their degraded residues 
need to pass an in vitro cytotoxicity and in vivo toxicity test to determine the suitability 
for biological applications. 
 
1.5 Biomedical applications of hydrogels 
Wichterle and Lim first described the polymerization of (hydroxyethyl methacrylate) 
(HEMA) monomer in the presence of water and other solvents in 1960 to obtain a soft, 
elastic, water-swollen, clear gel. This innovation served as a prelude to the application of 
hydrogels in the soft contact lens industry, and to the modern field of biomedical 
hydrogels as we know it today [46]. Interest and applications for hydrogels have since 
steadily grown over the last fifty years from soft contact lens to diagnostics [47], 
therapeutic devices [48] and implants [49].  Specifically, hydrogels prepared from PEG 
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and their derivatives such as polyethelyne glycol methacrylate (PEGMA), polyethelyne 
glycol dimethacrylate (PEGDMA) and polyethelyne glycol diacrylate (PEGDA) have 
been applied in a wide range of biomedical industries, including drug and protein 
delivery [50], cell encapsulation and delivery [51], wound dressing [52] and tissue 
regeneration [53]. To our interest, this thesis is focused mainly on the applications of 
PEG-based hydrogels in the latter field of tissue engineering and another novel area in 
antimicrobial therapeutics. 
 
1.5.1 Tissue engineering 
Tissue engineering has received much attention as a potential strategy to overcome many 
developmental or degenerative diseases worldwide [54, 55]. For successful tissue 
engineering, three components are essential - appropriate cell source, scaffold and 
appropriate microenvironment.  
 
1.5.1.1 Cell sources 
Stem cells have been widely used to regenerate diseased and damaged tissues in the past 
decade. These cells can be found in embryonic or adult tissues or derived from adult 
somatic cells that have been reprogrammed via gene transfer. The pluripotent ability of 
embryonic stem cells (ESC) enables them to differentiate into any type of cells and 
reproducible generation of differentiated cell lineages has been reported [56]. However, 
the ethical debate on using ESC has put a serious limitation in its application. Induced 
pluripotent stem cell (iPSC), first produced from mouse cells in 2006 and from human 
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cells in 2007, has marked a great advance in stem cell research [57]. It allows researchers 
to induce pluripotent stem cells without using the ethically controversial embryonic stem 
cells. However, the uncertainty and risk due to gene silencing associated with 
reprogramming iPSC from somatic cells has greatly limited its application in humans 
[58]. On the other hand, human mesenchymal stem cells (hMSCs) act as appropriate cell 
source given that they can be expanded with high efficiency and induced to differentiate 
into different lineages under defined culture conditions [59-61]. Moreover, hMSC is an 
autologous cell source that can avoid immune rejection associated with heterologous cells. 
There is also less concern with ethical issues and the risk of teratoma formation 
associated with ESC [62]. These properties make hMSCs desirable candidate cell source 
for tissue engineering.  
 
1.5.1.2 Scaffolds 
In classic tissue engineering, hMSCs are encapsulated on/in to a three-dimensional 
scaffold in the presence of bioactive signals to induce differentiation, and the resulting 
constructs are then transplanted as a replacement tissue for regenerative repair [63]. An 
ideal three-dimensional scaffold for tissue engineering should be able to provide a well 
defined microenvironment to promote cell adhesion, proliferation and differentiation with 
good biocompatibility and biodegradability for clinical usage. Hydrogels as injectable 
delivery vehicles for cells and genes in the area of tissue engineering have been 
intensively studied in the past decades [25, 64, 65]. In particular, in situ forming 
hydrogels are attractive scaffolds because of their high water absorbing capacity, three 
dimensional properties that well mimic some of the physicochemical aspects of natural 
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tissues and ability to deliver cells and genes through a minimally invasive way to the 
desired site. 
 
Although naturally derived biomaterials such as hyaluronic acid (HA) and collagen have 
been widely used as hydrogel scaffolds due to the good cell attachment properties [66, 
67], their application has been restricted because of the potential risk of infectious 
diseases [12]. In this respect, synthetic hydrogels which provide biocompatible scaffolds 
with tunable physiochemical and mechanical properties can be better candidates. Poly 
(ethylene glycol) (PEG)-based hydrogels with low immunogenicity and tunable 
properties has been one of the mostly studied synthetic polymers for tissue engineering 
[68-70]. In addition, the remarkable versatility of PEG macromer chemistry facilitates the 
incorporation of bioactive signals into the scaffolds for stem cell anchorage and 
controlled differentiation [71].   
 
The physical properties of PEG hydrogels can be tuned by changing the concentration of 
precursor material, the degree of crosslinking [72, 73] or using different degradable 
crosslinkers [74, 75]. However, most injectable PEG hydrogels are not able to remodel 
their structures when space is needed for cell growth, leading to limited cell proliferation. 
To overcome this problem, nanostructuring of scaffolds has recently been suggested to 
impart important structural cues and the subsequent interaction between the material and 
cells [76]. Nano-sized polymeric micelles can be formed from block or grafted 
amphiphilic polymers. With a crosslinkable functional group conjugated at one end of the 
hydrophilic block of the copolymer, a micelle can be formed with the functional groups 
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distributed on the surface of the micelle, which are accessible to crosslinking. These 
micelles can be utilized as a multi-arm crosslinker with great flexibility to prepare PEG 
hydrogels with tunable physicochemical and mechanical properties. Murakami Y et al 
[77] has successfully utilized an aldehyde-terminated crosslinkable micelle self-
assembled from PEG-poly (D, L-lactide) as a multi-arm crosslinker to provide fast 
gelation property and good mechanical property for homeostasis glue. 
 
1.5.1.3 Bioactive cues 
Besides physical properties, a host of bioactive cues has been discovered to guide hMSC 
differentiation, thus making PEG hydrogels not only a 3D scaffold for supporting stem 
cells, but also an active microenvironment for tissue regeneration. These signaling 
molecules include, but are not limited to: 1) paracrine signal factors such as transforming 
growth factor-β [78], bone morphogenetic protein [79], fibroblast growth factors and the 
Wnt family [80]; 2) transcriptional regulators such as the Sox family [81]; 3) extracellular 
matrix components such as collagen and proteoglycans like versican [82]. Their induced 
commitment and differentiation of mesenchymal stem cells are modulated by the 
concentration of protein and the duration of exposure [83].  
 
Specific or a combination of these signaling factors supplemented in the medium has 
been used to optimize the repair process in order to form stable and functional tissues 
[84]. Most of them are recombinant proteins with short half-lives, and are difficult to be 
effectively administered and maintain appropriate concentrations [85]. Gene transfer 
method has the potential to overcome these challenges by delivering therapeutical genes 
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to the right defect site via viral or non-viral gene vectors for sustained local expression of 
desired bioactive signals [86]. An ideal gene vector can efficiently deliver the gene of 
interest to the target cells and enable controlled and sustained gene expression for the 
desired biological effect.  
 
Although viral gene vectors have been widely utilized in tissue engineering due to their 
high efficiency [87], they suffer from potential immunogenicity and insertion 
mutagenesis. Non-viral vectors, on the other hand, are easier to synthesize and modify 
which can cater to specific applications with low immunogenicity and safe to use [88]. 
Natural and synthetic materials such as cationic polymers [89], inorganic nanoparticles 
[90] and carbon nanotubes [91] as non-viral gene carriers have been intensively explored. 
Among them, cationic polymers are the most attractive because they can be easily 
tailored to suit special requirements. High molecular weight branched polyethylenimine 
(PEI, 25 kDa) has been widely used as a ‘golden standard’ of non-viral gene vectors. 
However, its application has been limited due to its high cytotoxicity. There is a pressing 
need in finding the optimal gene carrier with high gene delivery efficiency yet low 
cytotoxicity. In this thesis, we thus attempt to address this gap by incorporating a novel 
cationic polymer into our hydrogel scaffold to allow for high transfection yet low toxicity 
for concurrent gene and cell delivery in tissue engineering. 
 
1.5.2 Antimicrobial applications 
As mentioned above, hydrogel materials have been widely used in tissue engineering as 
extracellular matrix substitution by providing a suitable physical and biological 
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microenvironment for host cell function. However, these materials may also serve as an 
ideal environment for opportunistic bacteria on biomedical implants [92].  
 
It has been reported that biomaterial-centered infections account for around 45% of all 
the nosocomial infections [93] and remained as a serious ongoing problem, regardless of 
advanced sterilization methods. These infections developed first through the bacterial 
adhesion and subsequent biofilm formation at the implantation site. When this happens, 
complicated surgical intervention to remove and/or replace the implant with possible 
function loss is needed and often inevitable [94]. Although preoperative sterilization and 
aseptic procedure help to limit the material-associated infections, there is a valid concern 
that the harsh sterilization conditions such as high temperature and irradiation may alter 
the material properties and destroy the therapeutics encapsulated, ultimately undermining 
the performance of the biomaterial [95].  
 
1.5.2.1 Antimicrobial agents 
Although antibiotics are the mainstay in the treatment of infections [96], recent studies 
have reported a less than desired efficacy against implant-associated infections [97]. 
There is also concern that such failure in treating implant-associated infections with 
conventional antibiotics may sooner or later result in antibiotic resistance in the 
pathogens [98]. These pathogens may acquire multidrug resistance through genetic 
mutation such as expression of drug altering enzymes and drug degrading enzymes, or 
drug efflux pumps capable of ejecting the antibiotics from the bacterial cells [99]. It has 
been reported that infections caused by multidrug resistant microorganisms failed to 
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respond to conventional antibiotics and raised high risk of death [100]. Thus there is an 
urgent need to develop new antimicrobial agents with mechanisms of action that are 
different from that of conventional antibiotics to overcome antibiotic resistance. 
 
Antimicrobial peptides (AMP) were first discovered in early 1980s by Boman et al 
through the study of natural defensive system of the multicellular organisms [101]. These 
peptides are widely distributed throughout the animal and plant kingdoms and more than 
one thousand candidates have been identified on record in the AMP database [102]. 
These candidates are generally cationic amino acids capable of approaching negatively 
charged bacterial cell membrane through electrostatic interaction and hydrophobic amino 
acids for insertion into lipid domain of bacterial membrane to lyse the bacterial cells 
membrane [103, 104]. This physical interaction presents an unique mechanism in bacteria 
killing, not easily overcome by the development of drug resistance via classical means.  
However, having that said, it has also been reported that few bacterial species has 
acquired AMP-resistance by genetically reducing the peptides-binding sites or secreting 
digestive proteases to destroy peptides [105]. 
 
Inspired by the efficiency and versatility of AMP in killing pathogens, antimicrobial 
polymers are being developed as new class of alternative antimicrobial agents [106]. a 
number of strategies have been adopted by chemists for antimicrobial polymer synthesis. 
There are several important parameters to be considered in designing these 
macromolecules including: hydrophobic/hydrophilic balance, cationic density, molecular 
weight and biodegradability [107, 108]. Firstly, amphiphilicity greatly affects the 
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interaction between the polymers and cellular membrane and the further selectivity of 
bacteria over mammalian cells [109]. Secondly, changing cationic density was reported 
to be used as an alternative method to tune amphiphilicity of the polymers. By increasing 
charge density while keep hydrophobic domain constant, Tew et al successfully reduced 
hemolytic activity of poly(norobornene) [110]. Thirdly, molecular weight affects both 
efficiency and toxicity of the antimicrobial polymers. The efficiency of antimicrobial 
polymers were reported to increase [111], decrease [109] and adopt a parabolic shape 
[110] with increasing molecular weight, depending the composition of the polymer and 
the nature of pathogens. Moreover, nanostructured antimicrobial polymers with great 
degradability have recently received great attention due to the enhanced antimicrobial 
activity by increasing the local charge density through nanostructure formation [112]. 
The high versatility and efficiency of antimicrobial polymers offer great promise to 
enhance the current antimicrobial treatments. However, these antimicrobial polymers 
lack of specificity towards bacterial cells and thus induce nonspecific toxicity to 
mammalian cells. Therefore there is an increasing need to develop antimicrobial agents 
with broad-spectrum antimicrobial activities and negligible toxicity to mammalian cells. 
 
1.5.2.2 Antimicrobial mechanisms 
Understanding the antimicrobial mechanism will provide important insight for better 
design of new antimicrobial agents with broad-spectrum antimicrobial activity and no 
toxicity to mammalian cells. In contrast to conventional small molecular antibiotics 
which pathogens develop resistance easily through mutation [113], synthetic 
macromolecular antimicrobials are reported to adopt a physical membrane disruption 
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mechanism (Figure 1.2) to minimize the likelihood of pathogen developing resistance. 
Based on studies of AMP, two sub-classified mechanisms have been proposed: pore 
forming and non-pore forming mechanisms [114, 115]. Pore-forming AMP 
perpendicularly inserts into the bilayer of microbial cell membrane and induces stable 
pores of around 10 nm in the outer layer of the cell membrane, disturbing the homeostasis 
of the cell metabolism and resulting in cell death [116]. On the other hand, non-pore 
forming AMP interacts with microbial cell membrane in a parallel manner and generally 
induce massive disruption of the cell membrane [117]. In both of these two mechanisms, 
AMP induces physical disruption to the microbial cell membrane structure and reduces 
the possibility of developing drug resistant microbes.  
 
Figure 1.2 Comparison in functional mechanism between small molecular antibiotics and 
macromolecular antimicrobials. (a) Mechanisms of antibiotic resistance in bacteria and (b) 
mechanisms of membrane-active antimicrobial peptides. Image reproduces with 
permission from [108]. Cpoyright (2012) Elsevier. 
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1.5.2.3 Antimicrobial hydrogels 
In order to reduce biomaterial-associated infections, hydrogel materials with 
antimicrobial activity have recently emerged as a rising trend to address these problems 
due to their wide application in biomedical applications [118, 119]. Typically, 
antimicrobial agents such as antibiotics, silver ions and niric oxide were loaded and 
released from hydrogels through active release strategies. For example, Wu et al has 
reviewed implanted medical devices with controlled drug released for infection 
prevention [120]. On the other hand, anti-infective silver, nitric oxide, known for their 
broad spectrum antimicrobial activity and nontoxicity to mammalian cells, have also been 
widely studied [121, 122]. Local administration of antimicrobial agents allows for 
selection of specific antimicrobial agent towards different pathogens at the implant sites. 
This approach not only enhances antimicrobial efficacy but also reduces the potential for 
systemic toxicity. However, their applications have been limited due to short half time of 
the cargoes in biological milieu for controlled release.   
 
Hydrogels with intrinsic antimicrobial activity has recently attracted great attention and 
risen as a promising alternative strategy to address these problems. Salick et al has 
recently described a hydrogel scaffold formed from self-assembling peptide with inherent 
antimicrobial activities against both Gram-positive and Gram-negative bacteria while at 
the same time allow mammalian cell proliferation during co-culture [123]. The 
antibacterial activity was attributed to the lysine-rich polycationic surface which disrupts 
the bacterial cell membrane upon contact. These β-hairpin peptide hydrogels have further 
been proven by the same group to be able to kill methicillin-resistant Staphylococcus 
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aureus [124]. Beside peptides, polyelectrolyte hydrogels prepared through ionic 
interaction between cationic chitosan and anionic γ-poly(glutamic acid) exhibited 
antibacterial activity against E. coli and S. aureus yet promoted cell proliferation for 
potential biomedical applications [125]. However, hydrogels made through ionic 
interaction may lack proper mechanical stability and the risk of dissolution of the system 
for specific biomedical application. Recently, Li et al has reported an antimicrobial 
hydrogel coatings based on dimethyldecylammonium chitosan (with high 
quaternization)-graft-poly (ethylene glycol) methacrylate (DMDC-Q-g-EM) and poly 
(ehylene glycol) diacrylate [126]. These hydrogels were formed and coated using 
photoinitiators and the proposed mechanism of the antimicrobial activity is by attracting 
the anionic microbial membrane section into the internal pores of the hydrogel like an 
‘anion sponge’. The major disadvantage of hydrogel prepared from peptides and chitosan 
is the short half life and the possible risk of immunogenicity. Therefore, hydrogels made 
from synthetic materials with broad spectrum antimicrobial activity and biocompatibility 
are highly needed. Moreover, these antimicrobial hydrogels have great potential in 
treating biofilm-related infectious diseases by providing high local dosage of 
antimicrobial agents yet introducing low systemic toxicity.  
 
1.5.2.4 Antibiofilm 
Biofilm, consists of bacteria and self-secreted extracellular polymeric substances (EPS) 
[127], differ from free planktonic microorganism in distinct structural and biochemical 
properties (Figure1.3). Biofilm-associated infections are responsible for more than 85% 
of surgical devices associated infections [128] and have become one of the leading causes 
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of the surgical device implantation failure [129-133]. In addition, bacterial biofilms make 
wound management and healing very difficult [134]. These biofilms tend to grow on inert 
surface or dead tissue and often at a too slow growth rate to develop overt symptoms 
[135].  
 
Although conventional antimicrobial agents are able to inhibit and/or kill the planktonic 
microorganisms, most of them remain ineffective in treating biofilm-associated infections 
[136, 137]. Host defense mechanism is incapable to kill the bacteria within biofilm and 
the resulted biofilms are extremely resistant to conventional antibiotics. Several 
mechanisms are reported to respond to the inherent resistance of biofilm to antimicrobial 
agents. Firstly, antimicrobial agents fail to penetrate the full depth of the biofilm [138]; 
secondly and most importantly, bacteria embedded in the biofilm is undergoing different 
metabolic state and slower growing rate due to the nutrient limitation in the biofilm as 
compare to planktonic bacteria cells [139]; thirdly, some of the cells in biofilm adopted a 
biologically programmed and protected biofilm phenotype to grow on a surface, and the 
complexity of the biofilm structure help to mimic the tissue of higher organisms [140]. 
Due to the insufficiency of standard antibiotic treatments, new approaches for preventing 
and treating drug-resistant infections need to be continually investigated. It is also one of 
our aims in this thesis to address this need with a new formulation of cationic hydrogels 
with broad spectrum antimicrobial activities in eliminating biofilms. 
 21 
 
Figure 1.3 Diagram showing the development of a biofilm as a five-stage process. Stage 
1: initial attachment of cells to the surface. Stage 2: production of EPS resulting in more 
firmly adhered “irreversible” attachment. Stage 3: early development of biofilm 
architecture. Stage 4: maturation of biofilm architecture. Stage 5: dispersion of single 
cells from the biofilm. The bottom panels (a-e) show each of the five stages of 
development represented by a photomicrograph of P. aeruginosa when grown under 
continuous-flow conditions on a glass substratum. Image reproduced with permission 
from [141]. Copyright (2002) Elsevier. 
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CHAPTER 2. HYPOTHESIS AND AIMS 
Tissue engineering technologies have risen in recent years as important strategies for the 
replacement and reconstruction of dysfunctional and degenerative tissues. The emerging 
field of tissue engineering combines the principles of engineering, biology and medicine 
for the development of functional tissue and cell substitutes. An ideal scaffold should be 
able to support cell-cell and cell-matrix interactions and degrade at a rate that 
synchronizes with the new tissue being regenerated over time. In this respect, in situ 
forming hydrogels are attractive options because of their injectability, high water 
absorbing capacity and three dimensional properties which mimic the physicochemical 
aspects of natural tissues. In this study, our aim is to synthesize nanostructured hydrogels 
with tunable physical properties to closely mimic an optimal microenvironment for cell 
and gene delivery. To provide an appropriate microenvironment, current research has 
been focused on using specific or a combination of signaling factors supplemented in the 
growth medium to provide bioactive signals. However, most of these bioactive molecules 
are recombinant proteins which can be easily degraded in vivo and a sustainable release is 
thus required. To overcome these challenges, we investigated a novel strategy combining 
the benefits of gene transfection methods in our synthetic PEG-based nanostructured 
hydrogel scaffolds to create a cohesive system to guide cell behavior. The hypothesis in 
this project is that genetic manipulations of hMSCs in a nanostructured hydrogel 
microenvironment will provide an effective approach to improve cell delivery for 
tissue engineering. 
 
To test this hypothesis, we propose 2 specific aims: 
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1) Synthesize and characterize injectable PEG hydrogel with varying amounts of micelle 
incorporated 
2) Evaluate cell viability and gene transfection efficiency of hMSCs encapsulated in the 
nanostructured hydrogels 
 
On the other hand, bacterial infections associated with the increasing utilization of 
biomaterial have attracted researchers’ attention and the bottleneck to treat biomaterial-
associated infections lies with the lack of broad spectrum antimicrobial and antibiofilm 
agents with less likelihood of drug resistance development and high selectivity to 
bacterial cells over mammalian cells. Of various antimicrobial agents, macromolecules 
have recently attracted immense attention in antimicrobial applications. These polymers 
balance charge and hydrophobicity to kill the pathogens through membrane disruption in 
order to avoid the development of drug resistance. In recent years, local delivery of 
existing antimicrobial agents by hydrogels greatly increased the antimicrobial efficacy to 
minimize the possible toxicity to mammalian cells and targeted the specific pathogen at 
the infection site to reduce the development of new strain of drug resistant pathogens. 
However, these hydrogels lack desirable shear thinning property for injection or topical 
applications. Moreover, degradability of the hydrogel remains as a valid concern in the 
clinical application of these hydrogels. To address these issues, we investigated a new 
strategy in combining the advantages of macromolecular antimicrobial polymers and 
remoldable hydrogel system to treat microbial infections. Herein we hypothesized that 
stereocomplex hydrogels with cationic polymer incorporated provide a broad 
spectrum of antimicrobial and antibiofilm activities both in vitro and in vivo. 
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To test this hypothesis, we propose 3 specific aims: 
1) Synthesize and characterize cationic polymers and stereocomplex PEG hydrogel with 
supramolecular structure 
2) Evaluate the antimicrobial and antibiofilm activities of the hydrogel with cationic 
polymer incorporated in vitro  
3) Investigate the in vivo activity of our hydrogel using the fungal keratitis animal model 
 
Work performed to carry out each specific aim is outlined as following: In chapter 3, we 
designed and synthesized hydrogels with different micelle contents to provide scaffolds 
with a wide range of physical property such as swelling ratio, porosity and degradability. 
Subsequently, the effect of micelle content on cellular behavior in the three dimensional 
hydrogel scaffold was explored in terms of cell survival and transfection. An optimal 
hydrogel scaffold with the highest cell viability and gene transfection was found to 
provide the best microenvironment to guide cell behaviors. In chapter 4, three cationic 
antimicrobial polymers were firstly screened in physical properties and toxicity test to 
obtain the best candidate for hydrogel incorporation. Hydrogels with cationic polymers 
incorporated were then formed through stereocomplexation and tested on various 
pathogens, including Gram-positive and Gram-negative bacteria, fungus and their 
biofilms. The potential hydrogel with broad spectrum antimicrobial and antibiofilm 
activities was further tested on a fungal keratitis animal model and showed comparable 
results as the commercially available antibiotic Amphotericin B. Lastly, in chapter 5, 
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conclusions and future perspectives derived from this thesis were provided in both 
application of tissue engineering and antimicrobial therapeutics. 
 
The successful completion of this thesis has broadened the applications of synthetic PEG-
based hydrogels and contributed in developing new strategies for hydrogels development 
in biomedical applications. The promising findings in this thesis should shed light on 
further research in designing well defined synthetic PEG-based hydrogel to meet specific 












CHAPTER 3. NANOSTRUCTURED PEG-BASED HYDROGELS WITH 
TUNABLE PHYSICAL PROPERTIES FOR GENE DELIVERY 
3.1 Background 
Artificial scaffolds that can physically support cell infiltration and biologically direct cell 
behavior remain a challenge in tissue engineering. An ideal 3-D scaffold for tissue 
engineering should be able to provide a well defined microenvironment to promote cell 
adhesion, proliferation and differentiation with biodegradability and good 
biocompatibility. Poly (ethylene glycol) (PEG)-based hydrogels, as injectable vehicles 
with low immunogenicity and tunable physicochemical properties, has received much 
attention in the area of tissue engineering [142]. However, traditional PEG-based 
hydrogels are randomly crosslinked and are short of the structure complexity that existed 
in the natural extracellular matrices (ECMs) [143]. Recently, nanostructured scaffolds 
have been suggested to impart important structural cues on the subsequent interactions 
between the material and cells [144]. For example, Zhang et al [145] reported a nanoscale 
hydrogel network self-assembled from peptide nanofiber with ~20 nm in diameter. These 
gels mimic natural ECM that is composed of an intricate interweaving of protein fibers 
with diameter ranging from 10 to several hundreds of nanometers. Chondrocytes seeded 
in these peptide hydrogels maintained their phenotype throughout 4-week period of in 
vitro culture, and developed a cartilage-like ECM rich in type II collagen and 
proteoglycans. In addition, physical incorporation of polymeric micelles into PEG 
hydrogels was also used to tune the storage modulus, thereby influencing cell behavior in 
the hydrogel [146]. Here we, for the first time, proposed a new strategy by covalently 
incorporating nanosized polymeric micelles self-assembled from an amphiphilic block 
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copolymer of PEG and biodegradable polycarbonate into PEG hydrogel networks 
(Scheme 3.1). With a crosslinkable vinyl group at the hydrophilic end (PEG) of the block 
copolymer, micelles can be formed with vinyl groups present on the shell, which are 
accessible to thiol groups of four-arm PEG for crosslinking via Michael addition. 
Moreover, hydrogels formed with flexible multi-arm micelle served as an improved 
approach for cell and gene delivery as comparison to hydrogels formed from rigid two-
arm PEG crosslinkers, which has reported by Shaoqiong Liu from our group [147].  
 
Human mesenchymal stem cells (hMSCs) are multipotent cells that can self-renew and 
differentiate into multiple cell lineages, making them an attractive cell source for tissue 
engineering. Gene transfer in the hydrogel has the potential to overcome the shortage of 
protein production associated with protein delivery through providing sustained 
expression of desired bioactive signal [148]. A number of non-viral gene carriers such as 
cationic polymers [149], peptide [150] and lipid [151] have been introduced to hydrogels 
for gene transfection due to the low immunogenicity and high safety as compared to viral 
carriers [152]. However, it is challenging to attain high gene transfection efficiency and 
low cytotoxicity in the hydrogel scaffold. Hence, there remains a practical need to 
develop effective gene delivery systems in the hydrogel. 
 
In this study, customized hydrogels with specific physical properties for cell adhesion 
and gene delivery is presented based on a formulation approach, where the constructs that 
are used are chemically incorporated into the gel. More specifically, we report 
biodegradable micelles-containing PEG hydrogels synthesized via Michael addition 
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chemistry, in which cationic bolaamphiphile/DNA complexes were physically 
encapsulated for gene transfer into hMSCs. The incorporation of the nanosized micelles 
provided an excellent means to tune physical properties of the hydrogels. RGD peptide 
was also chemically built into the hydrogel networks to enhance cell adhesion (Scheme 
3.1). The effect of micelle content on various physical properties such as swelling ratio, 
mechanical strength and porosity, and on the subsequent cell behaviors including 
viability and gene expression efficiency of hMSCs incorporated inside the hydrogels was 
investigated. A small molecular weight symmetrical cationic bolaamphiphile was used as 
a non-viral gene transfection vector [153]. Polyethylenimine (PEI, 25 kDa), known as the 
gold standard for in vitro gene transfection, was employed as a positive control. 
Luciferase-encoding plasmid was used as a reporter gene to study the effects of the 3-D 

















































Scheme 3.1 Synthetic scheme of micelle-containing peptide/PEG hydrogel. VS-PEG-PC 
micelles were formed in advance by dissolving the polymer directly in 0.3 M 
triethanolamine buffer (pH 8.0) and stabilized overnight before adding to the hydrogel 
precursor solution. RGD peptide was chemically built into the hydrogel networks for cell 
adhesion. Gelation was done in 37 °C incubator. 
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3.2 Material and Methods 
3.2.1 Materials  
All reagents were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. Tetra acrylate PEG (Mn 10,000 g/mol) and tetra sulfhydryl PEG (Mn 10,000 g/mol) 
were purchased from Sunbio Corporation (South Korea). RGD peptide (Mn 845.9 g/mol) 
with the sequence of Ac-GCGRGDSPG-CONH2 was obtained from GL Biochem 
(Shanghai) Ltd (China). SH-PEG-OH (Mn 5000 g/mol, PDI 1.03) was purchased from 
RAPP Polymere GmbH (Germany). Sparteine was stirred over CaH2, distilled in vacuum 
twice, and then stored in glove box. N-(3,5-trifluoromethyl)phenyl-N’-cyclohexylthiourea 
(TU) was prepared according to our previous protocol [154]. TU was dissolved in dry 
THF, stirred with CaH2, filtered, and freed of solvent in vacuo. Phosphate-buffered saline 
(PBS) and tris ethylenediaminetetraacetate (TE) buffer were obtained from 1st BASE Pte 
Ltd (Singapore) and diluted to the intended concentrations before use. Luciferase-
encoding plasmid was bought from Carl Wheeler, Vical (U.S.A). 1 kb DNA ladder was 
purchased from New England Biolabs, while ethidium bromide solution was obtained 
from Biorad Laboratories (U.S.A.). Reporter lysis buffer and luciferin substrate were 
purchased from Promega (U.S.A.) and bicinchoninic acid (BCA) protein assay reagent 
was purchased from Pierce (U.S.A.). Plasmid DNA encoding the 6.4 kb firefly luciferase 
gene driven by the cytomegalovirus (CMV) promoter was obtained from Carl Wheeler, 
Vical (U.S.A.), amplified in Escherichia coli DH5α and purified using Endofree Giga 
plasmid purification kit from Qiagen. Human bone marrow mesenchymal stem cells 
(hMSCs) and mesenchymal stem cell growth medium (MSCGM) were obtained from 
Lonza (U.S.A.). 
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3.2.2 Synthesis of VS-PEG-PC polymer 
Amphiphilic diblock polymer (vinyl sulfone-PEG-polycarbonate, i.e. VS-PEG-PC) was 
synthesized by Dr. Chuan Yang from the Institute of Bioengineering and Nanotechnology 
(IBN). The polymer is capable of self-assembly into nanosized micelles in aqueous 
solution with crosslinkable vinyl sulfone group on the micelle shell.  
3.2.3 Micelle formation and characterization 
VS-PEG-PC micelles were formed in advance by dissolving the polymer directly in 0.3M 
triethanolamine buffer (pH 8.0) and stabilized overnight. Critical micelle concentration 
(CMC) of the polymer in triethanolamine buffer was estimated by fluorescence 
spectroscopy using pyrene as a probe [155]. Fluorescence spectra were recorded on a LS 
50B luminescence spectrometer (Perkin-Elmer, U.S.A) at room temperature (25 ± 2C). 
Typically, 10 μL pyrene in acetone solution (6.16 × 10−5 M) was added to containers and 
the acetone was left to evaporate. Polymer solutions (1 mL) at various concentrations 
were added into the containers and left to equilibrate for 24 hours. The final pyrene 
concentration in each sample was 6.16 × 10
−7
 M. The intensity (peak height) ratios of 
I337/I334 from the excitation spectra were evaluated as a function of polymer concentration. 
The CMC was taken from the intersection between the tangent to the curve at the 
inflection and tangent of the points at low concentrations. Hydrodynamic diameter of the 
micelles was measured using a Zetasizer (3000 HAS, Malvern Instrument, U.K) at room 
temperature (25 ± 2C). Micelle morphology was observed under a FEI Tecnai G2 F20 
transmission electron microscope (TEM) using an acceleration voltage of 200 KeV. To 
prepare the TEM sample, several drops of micelle solution at a concentration of 1000 
mg/L containing 0.2% (w/v) of phosphotungstic acid were placed on a formcar/carbon-
 31 
coated 200 mesh copper grid and left to dry under room temperature (25 ± 2C) prior to 
TEM observation. 
 
3.2.4 Synthesis of micelles-containing PEG hydrogels 
In a typical hydrogel preparation (e.g. 20% micelle), tetra acrylate-terminated PEG (PEG-
AC) (2.6 mg, 0.26 μmol) was dissolved in 21.5 μl of 0.3M triethanolamine buffer (pH 8.0) 
to make a 12 (w/v)% precursor solution. 5.4 μl of VS-PEG-PC micelle solution (12 
(w/v)%) as prepared in Section 3.2.3 was added to the precursor solution, followed by the 
addition of 10 μl of RGD solution (5 mg/ml) with final concentration of 1 mM. The 
reaction solution was kept in a 37C incubator for 30 min. 23.2 μl of tetra sulfhydryl PEG 
crosslinker in triethanolamine buffer (12 (w/v)%) was then added to the mixture to make 
1:1 molar ratio of SH in tetra sulfhydryl PEG and (AC+VS) (sum of acrylate groups in 
tetra acrylate PEG and vinyl sulfone groups in VS-PEG-PC). The final precursor 
concentration was 10 (w/v) %. The reaction mixture was kept in 37 C as three 20 μl 
drops and hydrogel formed in minutes.  
 
3.2.5 Physical characterization of hydrogels 
As reported previously by our laboratory [74], the gelation time was determined by the 
vial tilting method. When the sample showed no flow, it was regarded as a gel. The 
hydrogels were placed in PBS buffer at 37 C for 24 hours and weighed periodically, 
swelling ratio was calculated from the formula: Swelling ratio = (Ww-Wd)/Wd, where Ww 
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represents the weight of swollen gels, Wd represents the weight of the freeze-dried gels. 
All samples were analyzed in triplicate.  
 
The internal morphologies of the freeze-dried gels were observed using a field emission 
scanning electron microscope (FESEM, Model JSM-5600, Japan). The hydrogels were 
immediately frozen in liquid nitrogen prior to freeze drying to keep the morphology 
intact. The cross-sectioned hydrogels were mounted on metal holders and vacuum coated 
with a platinum layer before SEM examination. 
 
Rheology experiments were performed at room temperature (25 ± 2C) using a control-
strain rheometer (ARES 100FRTN1, Rheometric scientific). The dynamic storage 
modulus (G’) and loss modulus (G’’) were examined as a function of frequency from 1 to 
100 Hz. The measurements were carried out at strain amplitude (γ) of 5% to ensure the 
linearity of viscoelasticity. Gel yield was calculated from the formula: Gel yield = Wd/Wi, 
where Wd represents the weight of the freeze-dried gels, and Wi represents the weight of 
the total starting materials. All samples were analyzed in triplicate.  
 
3.2.6 Culture and encapsulation of hMSCs in the hydrogels 
hMSCs were cultured in Mesenchymal Stem Cell Growth Medium (MSCGM) (Lonza, 
U.S.A) and incubated at 37 C, 5% CO2 incubator. The medium was changed every other 
day. Cells were harvested with PBS containing 0.025% (W/V) trypsin and 0.01% EDTA, 
centrifuged and subcultured to passage 4 in the MSCGM medium. Hydrogels for the 
study of cell encapsulation were also prepared according to the protocol described in 
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Section 3.2.4. The cells were resuspended in 20 µl of MSCGM medium and then mixed 
with the gel precursors prior to crosslinking. Cell density was 10 million per ml. Droplets 
of hydrogel were kept in 37 C incubator and formed within minutes. The gels were then 
transferred to a 96 well plate and cultured in 150 µl of MSCGM medium. Medium was 
changed hourly for the first 2 hours and every day for the following 2 days.  
 
To visualize the distribution of hMSCs inside the PEG hydrogel, confocal images were 
obtained using a LIVE/DEAD
@
 viability/cytotoxicity kit (Invitrogen, U.S.A). Briefly, 10 
µL of ethidium homodimer-1 and 5 µL of calcein AM from the kit were diluted with 10 
mL of PBS to make the staining solution. Each gel was stained with 100 µL of the 
staining solution for 30 min at room temperature (25 ± 2C) in the dark and imaged with 
an inverted confocal microscope (Carl Zeiss, U.S.A) 
 
3.2.7 Cell viability in the hydrogels 
The viability of hMSCs in the hydrogel was quantified by MTT assay in triplicate. This 
assay is based on the cleavage of MTT (a yellow tetrazolium salt) into insoluble purple 
formazan crystals by the mitochondrial enzymes of viable cells. MTT solution was added 
to the hydrogel and incubated for 4 hours. The hydrogel constructs were then collected 
and homogenized in 400 µL of DMSO with tissue ruptor (Qiagen, U.S.A). An aliquot of 
100 µL was taken from each well and transferred to a fresh 96-well plate. The plates were 
then assayed at 590 nm with a microplate reader (Tecan, Switzerland). The results were 
expressed as a percentage of the cell viability in the hydrogel without the micelles.  
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3.2.8 Characterization of polymer/DNA complex 
The particle size and zeta potential of the complexes were measured using the Zetasizer 
(3000 HAS, Malvern Instrument, U.K). Gel electrophoresis was performed to evaluate 
the DNA binding ability of the cationic bolaamphiphile. Cationic bolaamphiphile/DNA 
complexes containing 1.5 µg of luciferase-encoded plasmids were prepared with various 
N/P ratios ranging from 2 to 14. The complexes were electrophoresed on 1% agarose gel 
(stained with 4 µL of 0.5 µg/mL ethidium bromide per 50 mL of agarose solution) in 
0.5×TBE buffer at 80 mV for 60 min. The gel was then analyzed on a UV illuminator 
(Chemi Genius, Evolve, Singapore) to show the position of the complexed DNA relative 
to that of naked DNA.  
 
3.2.9 Gene transfection in 2D cell culture plate 
Gene transfection of bolaamphiphile/DNA complexes was performed in 24-well plates. 
The cell were seeded at a density of 5 ×10
4
 cells/well and cultivated in 500 μl growth 
medium for luciferase transfection. After 24 hours incubation, the culture medium was 
replaced with fresh medium and the complex solution (50 μl) containing 2.5 μg luciferase 
reporter gene was added to each well. After 4 hours incubation, the culture media were 
replaced with the fresh medium and incubated for 24 hours before being washed with 0.5 
ml of PBS. Reporter lysis buffer (0.2 ml) was then added to each well to lyse the cells. 
The cell suspension was subjected to 2 cycles of freeze (-80 ºC, 30 min) and thaw (on 
ice), then centrifuged at 13,000 rpm at 4 ºC for 10 min to remove the cell debris. 20 μl of 
supernatant of the cell lysate was mixed with 100 μl of luciferase substrate and the 
relative light units (RLU) was measured using a lumimometer (Lumat LB9507, Berthold, 
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Germany), and normalized to protein content measured using BCA protein assay (Pierce). 
Naked DNA was used as negative control and PEI at N/P ratio 10 was used as positive 
control in this experiment. 
 
3.2.10 Cytotoxicity studies of polymer/DNA complex in 2D cell culture plate 
Cytotoxicity of bolaamphiphile/DNA complexes was performed in 96-well plates. Briefly, 
hMSCs were seeded at a density of 1 ×10
4
 cells/well and cultivated in 100 μl of growth 
medium. The culture medium was replaced with fresh medium after 24 hours incubation. 
Following that, 10 μl of complex solution was added into each well. After 4 hours, the 
culture medium was replaced with fresh medium and incubated for another 24 hours. The 
medium was then replaced with 100 μl of fresh medium together with 10 μl of MTT 
solution (5 mg/ml) and incubated for 4 hours. The medium was removed and 150 μl of 
DMSO was added to dissolve the formazan crystal formed. The resulted purple solution 
(100 μl) was taken and absorbance reading was measured at 550 nm and 690 nm using a 
microplate reader (PowerWave X, Bio-Tek Instruments). The difference of absorbance 
was taken and the results were expressed as a percentage of that of the negative control.  
 
3.2.11 Gene transfection in 3D hydrogels with different micelle content 
Cationic bolaamphiphile/DNA complexes containing 1.5 µg of luciferase-encoded 
plasmids with a series of N/P ratios were added to each hydrogel. Cationic 
bolaamphiphile/DNA complexes were formed by adding equal volume of bolaamphiphile 
solution into DNA solution, and incubated for 30 min. The complexes were then mixed 
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with hMSCs and incubated for 15 min at room temperature (25 ± 2C). The cell 
suspension was then encapsulated into polycarbonate micelles-containing PEG hydrogels 
by mixing with the gel precursors prior to crosslinking. The gels were formed within 15 
min at 37C. The gels were transferred to a 96 well plate, and the medium was changed 
hourly for the first 2 hours and every day for the following 2 days. On the 4
th
 day, the gel 
was washed twice with PBS and homogenized in 200 mL of reporter lysis buffer. The 
relative light unit (RLU) was measured using a luminometer (Bio-rad, U.S.A) and was 
normalized to protein content measured using the BCA protein assay (Bio-Rad, U.S.A). 
PEI/DNA complexes were used as a positive control and naked DNA was employed as a 
negative control. PEI/DNA complexes were made at N/P 10 as at this N/P ratio they 
induced high gene expression efficiency, yet provided more than 50% cell viability. 
 
3.2.12 Cytotoxicity studies of polymer/DNA complex in 3D hydrogels 
Cell viability in the hydrogel after gene transfection with the cationic 
bolaamphiphile/DNA complexes was tested by MTT assay in triplicate (Section 3.2.10). 
On the 4
th
 day, the gel was washed twice with PBS. MTT solution was added to the 
hydrogel and incubated for 4 hours. The constructs were then collected and homogenized 
in 400 mL of DMSO with tissue ruptor (Qiagen, U.S.A). The results were expressed as a 
percentage of the cell viability in the hydrogel without the bolaamphiphile/DNA 
complexes incorporated.  
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3.2.13 Statistical analysis 
All data are presented as mean ± SD. The statistical significance of the data was 
evaluated by two-tailed Student's t-Test. P<0.05 was considered statistically significant. 
 
 3.3 Results and discussion 
3.3.1 Synthesis of VS-PEG-PC polymer 
Vinyl sulfone-functionalized PEG-b-polycarbonate (VS-PEG-PC, Scheme 3.2) is an 
amphiphilic diblock copolymer synthesized by Dr. Chuan Yang from the Institute of 
Bioengineering and Nanotechnology (IBN). The detailed synthesis and characterization 




















Scheme 3.2 Chemical structure of Vinyl sulfone-PEG-b-polycarbonate. 
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3.3.2 Micelle formation and characterization 
VS-PEG-PC has a very low critical micelle concentration (CMC), which is about 7.1 
mg/L in DI water, indicating that it can easily self-assemble into micelles by simply 
dissolving into water at very low concentrations. The CMC value of the polymer 
decreased to 1.6 mg/L (Figure 3.1) in TEOA buffer because of the presence of salts in the 
buffer. The particle size of the micelles in DI water was 56 nm with a narrow 
polydispersity index of 0.19. As shown in Figure 3.2, VS-PEG-PC self-assembled into 
distinct spherical nanoparticles as a result of the combination of hydrophobic and 
hydrogen-bonding interactions within the hydrophobic blocks of poly(urea-random-ethyl 
carbonate). The particle size estimated from the TEM pictures was in agreement with that 
obtained from dynamic light scattering analysis. To investigate if the formation of the 
polymeric micelles was affected by other precursors during the hydrogel formation, the 
particle size of the micelles was measured in the presence of tetra acrylate PEG. It was 
found that the presence of tetra acrylate PEG did not affect the micelle size, indicating 
that the micelles were most likely intact during the hydrogel formation. The nanosized 
micelles embedded in the hydrogel may offer great advantages in directing cell behaviors 

































Figure 3.1 Determination of critical micelle concentration (CMC) of VS-PEG-
polycarbonate. VS-PEG-PC micelles were formed and stabilized overnight before 
measurement. 
 
                                
Figure 3.2 A typical TEM image of micelles prepared using VS-PEG-PC in DI water 
with polymer concentration of 0.5 mg/mL. Scale bar: 50 nm. 
 
 40 
3.3.3 Synthesis and physical characterization of micelle-containing hydrogels 
Michael addition chemistry offers the possibility of obtaining hydrogel in situ under mild 
physiological conditions, which avoids the use of toxic initiators and UV exposure 
involved in the photo polymerization process. Therefore, it was employed to synthesize 
micelle-containing PEG hydrogels. Both a tetra acrylate PEG solution and the vinyl 
sulfone-functionalized polycarbonate (VS-PEG-PC) micelle solution were mixed, 
followed by the addition of a thiol-containing RGD peptide (a cell adhesion receptor 
binding motif). Gelation occurred within minutes upon the introduction of tetra 
sulfhydryl PEG. 
 
Table 1 summarizes the physical properties of hydrogels formed with different micelle 
contents. The storage modulus (Ge) of the micelles-incorporated hydrogels ranged from 
900 Pa to 3000 Pa., indicating that stiffness of the hydrogels can be adjusted by 
varying the micelle content. Ge was not affected significantly when the micelle content 
was 20% or 40% as compared to hydrogels without micelles (P>0.05). For instance, the 
Ge values of the hydrogels without micelles (Gel 1) and with 20% (Gel 2) and 40% (Gel 
3) micelles were 2522, 2691 and 2475 Pa, respectively. We have previously reported that 
Ge of PEG/RGD hydrogel decreased with increasing RGD contents because of the 
presence of elastically ineffective dangling RGD ends in the hydrogels [74]. However, 
this effect may be compromised by the presence of well-defined VS-PEG-PC micelles 
with multiple crosslinkable units. Notably, storage modulus and gel yield decreased 
significantly when the micelle content was increased to 60% (Gel 4) and 80% (Gel 5). 
The decreased Ge and gel yield can be directly related to lower crosslinking density of 
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hydrogel networks, which was caused by the decreased molar concentration of -SH and 
(AC+VS) crosslinkable groups. In addition, the lower crosslinking density at higher 











1 0 100 2522 ± 56 97.8 ± 4.8 3.0 
2 20 80 2691 ± 51 92.7 ± 3.3 5.5 
3 40 60 2475 ± 30 90.2 ± 3.6 7.0 
4 60 40 1855 ± 71 79.5 ± 1.0 9.5 
5 80 20 902 ± 27 75.3 ± 2.8 15.0 
 
Table 3.1 Physical properties of hydrogels. (Stoichiometry of (vinyl sulfone + acrylate) 
to thiol groups was 1.0 for all formulations. Gvalue at frequency of 1 Hz was defined as 
Ge)。 
 
As shown in Figure 3.3, swelling ratio of the hydrogels increased with increasing micelle 
content, indicating more hydrated status. The higher swelling ratio of hydrogels with 
increasing micelle content may be due to their more porous structures (Figure 3.4). For 
example, when the content of micelles increased from 0 to 80%, the swelling ratio 























Figure 3.3 Effects of micelle content on the swelling ratio of the hydrogels. The 
hydrogels were placed in PBS buffer at 37 C for 24 hours, swelling ratio was calculated 
from the formula: Swelling ratio = (Ww-Wd)/Wd, where Ww represents the weight of 
swollen gels, Wd represents the weight of the freeze-dried gels. All samples were 
analyzed in triplicate. 
 
Figure 3.4 shows SEM images of internal structure of the freeze-dried hydrogels with 
different micelle content, which is characterized by high porosities. It is observed that the 
size of pores increased with increasing micelle content due to decreased crosslinking 
degree. In particular, when the content of the micelles was 80%, the pores inside the 




Figure 3.4 A typical SEM image of cross-sectioned hydrogel with different contents of 
micelles. The hydrogels were immediately frozen in liquid nitrogen prior to freeze drying 




For an ideal biodegradable hydrogel system, the hydrogel should be able to degrade at an 
appropriate rate that synchronizes with the new tissue being regenerated over time. 
Hydrogel degradation was normally accompanied with increased weight loss, higher 
swelling ratio and decreased storage modulus [157]. A typical storage modulus profile 
over time for hydrogel with 20% micelles is illustrated in Figure 3.5. The Ge of Gel 2 
decreased steeply during the first 5 days and slowed down to a constant rate up to 28 days, 
likely due to dissociation of the micelles, followed by the hydrolytic degradation of 
acrylate-PEG component. The gradual degradation profile and relative long degradation 



























Figure 3.5 Storage modulus (Ge) of the hydrogel with 20% micelles changes as a 
function of time for 28 days. Hydrogels were incubated in PBS in 37 °C incubator and 
rheology measurement was carried out periodically.  
 
3.3.4 Cell viability in the hydrogels 
Previous studies have indicated that the cell behavior in the hydrogel is affected by 
several factors including stiffness, porosity and degradation rate of the hydrogel [158, 
159]. These parameters are highly intertwined. In order to study the effect of micelles on 
cell behavior, cell viability assay was first performed. As can be seen from Figure 3.6, 
cell viability in the hydrogel with 20% and 40% micelles was significantly higher than 
that in the hydrogel without micelles (P<0.005). This may be because more space has 
been provided by micelles incorporated into the hydrogels, which in turn allowed for 
better hMSCs migration and proliferation. In addition, with more porous structures, the 
cells obtained more and faster oxygen and nutrient exchanges for cell proliferation, as 
compared to the less porous hydrogel without micelles. However, when hydrogels 
became softer as the micelle content increased to 60% and 80%, cell viability started to 
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decrease to that of the hydrogel without micelles. This may be because these hydrogels 
were too soft to support cell growth. Overall, the hydrogel with 20% micelles provided an 
optimal scaffold with a structure that is sufficiently stiff yet porous enough for cell 























Figure 3.6 Effect of the micelle content on the viability of hMSCs in the hydrogel. 
hMSCs were incubated in the hydrogel for 4 days. MTT test was carried out by adding 
MTT solution to the hydrogel and incubating for 4 hours. The hydrogel constructs were 
then collected and homogenized with tissue ruptor. Aliquots of the solution were then 
assayed with a microplate reader. The results were expressed as a percentage of the cell 
viability in the hydrogel without the micelles. 
 
Confocal images (Figure 3.7) further showed that cells encapsulated inside the hydrogel 
tend to adopt a rounded morphology - a phenomenon that agrees with previous findings 
[160]. hMSCs were evenly distributed especially in the hydrogels with 0 to 40% micelles. 
The number of live cells, as indicated green in the confocal images, was consistent with 
the cell viability assay, i.e. the highest number of viable cells was found inside the 
hydrogel with 20% micelles. A lower number of cells were observed in the hydrogels 
with 60% and 80% micelles possibly because dead cells were washed off during sample 
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preparation. Therefore, the hydrogel with 20% micelles was chosen for further evaluation 
on gene transfection, and the hydrogel without micelles was used as a control. 
 
0% micelle 20% micelle 40% micelle 
60% micelle 80% micelle 
A B C 
D E 
 
Figure 3.7 Confocal images of hMSCs incorporated in the hydrogels with different 
contents of micelle. LIVE/DEAD viability/cytotoxicity kit was used to stain hMSC in the 
hydrogels (A) 0%, (B) 20%, (C) 40%, (D) 60% and (E) 80%. Scale bar: 50 μm. Green 
represents live cells and red represents dead cells.  
 
3.3.5 Characterization of polymer/DNA complex  
The Bolaamphiphile polymer, MK397, is a cationic polymer synthesized as a gene vector 
by Dr. Majad Khan from the Institute of Bioengineering and Nanotechnology (IBN). It 
contains both primary and secondary amine for DNA binding and endosomal escape and 
amine bond for potential biodegradability. The detailed synthesis and characterization of 





Scheme 3.3 Chemical structure of bolaamphiphile polymer (MK397) 
 
Polymer/DNA complexes were formed by adding different volume of polymer solution 
into an identical volume of reporter gene solution at different N/P ratios. The particle size 
and zeta potential of the polyplexes were measured by Zetasizer at room temperature (25 
± 2C). As shown in Figure 3.8, the particle size of the DNA complexes slightly 
increased at N/P 3 and gradually decreased to a level of below 200 nm from N/P 5 
onwards. The Zeta potentials of the complexes increased with increasing N/P ratio and 
obtained a positive charge at N/P ratios higher than 5. The results from the agarose gel 
electrophoresis experiments showed that the bolaamphiphile polymer (MK397) exhibited 
strong DNA binding ability, and complete retardation of DNA was observed at N/P 2 
(Figure 3.9). These findings clearly demonstrate that the bolaamphiphile polymer 
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Figure 3.8 Particle size and zeta potential of bolaamphiphile/DNA complexes. 
Polymer/DNA complexes were formed by adding different volume of polymer solution 




Figure 3.9 Electrophoretic mobility of DNA in bolaamphiphile/DNA complexes at N/P 
ratios specified. Lane 1: naked DNA; last lane: blank polymer. Cationic 
bolaamphiphile/DNA complexes were prepared and electrophoresed with various N/P 
ratios ranging from 2 to 14. The gel was analyzed on a UV to show the position of the 
complexed DNA relative to that of naked DNA.  
 
 
N/P ratio:        0      2     4     6     8    10   12   14 
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3.3.6 Transfection efficiency in 2D cell culture plate 
To examine the applicability of the bolamphiphile as an ideal gene vector for hMSC 
transfection, we first determined the transfection efficiency of MK397 over a range of 
N/P ratios in 2 dimensional cell culture plate. 
As shown in Figure 3.10, no gene transfection was observed at N/P ratios 3 to 10 
followed by a 1000 fold jump at N/P ratio 15. Transfection efficiency increased as the 
N/P ratio was increased from 10 to 20 and then reached a plateau. The highest 
transfection efficiency obtained was significantly higher than that achieved using 
PEI/DNA (P<0.05). Several reasons may be offered to explain why the bolaamphiphiles 
were so efficient in gene delivery. Firstly, the hydrophobic component in the 
bolaamphiphile enhanced gene binding and cell membrane penetration. More importantly, 
the presence of primary and secondary amine in bolaamphiphile greatly improved 
endosomal buffering capacity and thus enhanced DNA release from the complexes, 
which in turn helped prevent DNA from degradation in the harsh endosomal environment 
[161].  
3.3.7 Cytotoxicity of polymer/DNA complex in 2D cell culture plate 
An ideal non-viral gene delivery vector should show a low cytotoxicity to the target cells. 
The high cytotoxicity induced by PEI has largely limited its application in clinical 
settings, despite its high gene transfection efficiency [162]. The cytotoxicity profile of the 
bolaamphiphile was subsequently determined over a wide range of N/P ratios from 3 to 
30. As shown in Figure 3.11, the bolaamphiphile/DNA complexes induced no 
cytotoxicity against hMSCs at N/P ratios below 10. Beyond N/P ratios of 10, however, a 
decreasing trend in cell viability was observed. Notably, the effect of the 
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bolaamphiphile/DNA on cell viability was comparable to that of the PEI/DNA complex 

























Figure 3.10 Gene transfection of bolaamphiphile/DNA complex in 2D cell culture plate. 
Complex solution was added into fresh media at various N/P ratios and incubated for 4 

























Figure 3.11 Cytotoxicity studies of bolaamphiphile/DNA complex in 2D cell culture 
plate. Complex solution was added into fresh media at various N/P ratios and incubated 
for 4 hours. hMSCs were further cultured for 4 days before carrying out the cell viability 
analysis by MTT assay.  
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3.3.8 Transfection efficiency in 3D hydrogels with different micelle content 
It was reported that the non-specific interaction between the hydrogel component and 
PEI/DNA complexes affected the complex release and thus rendered the hydrogel as a 
local reservoir for the DNA complexes [163]. After determining the transfection 
efficiency of the cationic bolaamphiphile in the two dimensional environment, we next 
tested its gene transfection efficiency in the 3D hydrogels with different micelle content.  
 
In both hydrogel scaffolds with 0% and 20% micelles, luciferase expression level 
induced by the cationic bolaamphiphile/DNA complexes increased with increasing N/P 
ratio from 3 to 7.5, with the maximal level observed at N/P 7.5 (Figure 3.12). The highest 
luciferase expression level mediated by the cationic bolaamphiphile/DNA complexes was 
significantly higher than PEI in both hydrogels with and without 20% micelles (P<0.05). 
For instance, the luciferase expression level induced by the cationic bolaamphiphile/DNA 
complexes at N/P 7.5 was 33 times higher than that mediated by PEI in the hydrogels 
with 20% micelles. This may be because the presence of hydrophobic components in the 
bolaamphiphile promoted cellular uptake of the complexes, leading to high gene 
expression efficiency. 
 
The effect of micelle content on gene expression efficiency was further studied at the 
optimal N/P ratio of 7.5. As shown in Figure 3.13, luciferase expression levels in the 
hydrogel with 20% micelles was significantly higher than those in the hydrogel without 
micelles for the bolaamphiphile at all N/P ratios (P<0.05). The enhanced gene expression 
may be attributed to the higher cell viability in the hydrogel with 20% micelles. In 
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addition, porosity can play an important role in gene transfection in scaffolds [164]. A 
denser hydrogel network may prevent the cationic bolaamphiphile/DNA complexes from 
being in contact with the cells. However, the luciferase expression level in the hydrogels 
started to decrease as the micelle content increased from 40% to 80%. This may be 
attributed to a highly porous and soft scaffold structure that may not be able to support 
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Figure 3.12 Luciferase expression level in the hMSCs incorporated in the hydrogels with 
and without 20% micelles. hMSCs mixed with complex solution at various N/P ratios 
were added into hydrogels and incubated for 4 hours. The hydrogel constructs were 

























Figure 3.13 Luciferase expression level in the hMSCs incorporated in the hydrogels with 
different micelle content. hMSCs mixed with complex solution at N/P ratio 7.5 were 
added into hydrogels and incubated for 4 hours. The hydrogel constructs were further 
cultured for 4 days before carrying out the reporter gene analysis. 
 
3.3.9 Cytotoxicity of polymer/DNA complex in 3D hydrogels 
As aforementioned, cytotoxicity is an important parameter used to evaluate cationic 
polymers as non-viral gene transfection vectors. The cytotoxicity is believed to be related 
to gene transfection efficiency [165], and may be caused by electrostatic interaction with 
negatively charged glycocalyx of the cell surface [166]. Cytotoxicity of 
bolaamphiphile/DNA complex was much lower than PEI at N/P ratio below 15 in 2D cell 
culture plate (Figure 3.11). Lower N/P ratios were required to achieve successful gene 
transfection in the 3D hydrogel environment as hydrogels serve as a local gene reservoir 
with intimate contact with the encapsulated cells. As revealed in Figure 3.14, there was 
no significant cytotoxicity of the cationic bolaamphiphile/DNA complexes against 
hMSCs at all the N/P ratios from 3 to 10 (P=0.3-0.6). This was in sharp contrast to PEI, 
which induced much higher cytotoxicity against hMSCs in the hydrogels (P<0.05). The 
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cationic bolaamphiphile exhibited small particle sizes and relatively low zeta potentials 
after complexation with DNA, leading to little cytotoxicity at low concentrations. 
Collectively, hydrogels with 20% micelles provided optimized mechanical support, 
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Figure 3.14 Viability of hMSCs in the hydrogel after incubation with 
bolaamphiphile/DNA and PEI/DNA for 4 days at various N/P ratios specified.  
 
3.4 Conclusion 
In this Chapter, we describe synthetic hydrogels made from PEG with micelles self-
assembled from a biodegradable and crosslinkable polycarbonate-based amphiphilic 
block copolymer. Increasing the content of the micelles from 0 to 80% led to increased 
porosity and tunable mechanical property of the hydrogels. The hydrogel with 20% 
micelles provide the best balance among hydrogel stiffness, flexibility and porosity for 
cell survival, leading to the highest viability of hMSCs. The cationic 
bolaamphiphile/DNA complexes induce higher gene expression efficiency in the 
hydrogels than the PEI/DNA complexes, yet show no cytotoxicity. The gene expression 
 55 
level in hMSCs in the hydrogel with 20% micelles was the highest as compared to that in 
the other hydrogels. Overall, the hydrogel with 20% micelles offers an optimal scaffold 
with ideal physical properties for cell growth and transfection. Therefore, incorporating 
nanoparticles into the hydrogels is a useful strategy to tune the physical properties of 
hydrogel scaffolds and subsequently control cellular behavior in a 3-D environment. 
These biodegradable hydrogels can be an excellent platform for cell and gene delivery in 





CHAPTER 4. STEREOCOMPLEX HYDROGEL WITH SUPRAMOLECULAR 
STRUCTURES FOR ANTIMICROBIAL AND ANTIBIOFILM ACTIVITIES 
4.1 Background 
As mentioned in Chapter 3, biomaterials have been widely used in tissue engineering and 
other biomedical applications. However, bacterial infections associated with the 
increasing utilization of biomaterial have attracted researchers’ great attention and the 
bottleneck to treat biomaterial-associated infections lies with the lack of broad spectrum 
antimicrobial and antibiofilm agents with less likelihood of drug resistance development 
and high selectivity to bacterial cells over mammalian cells. To broaden the application 
of synthetic PEG-based hydrogels, we continued to explore the application of cationic 
hydrogels for antimicrobial and antibiofilm activities. 
 
The development of antibiotic-resistant bacteria has caused a myriad of new challenges 
within the healthcare industry.  Skin infections caused by drug-resistant Staphylcoccus 
aureus (MRSA) account for more than half of all reported cases of S. aureus skin 
infections in the United States [167]. Furthermore, due to the extremely high occurrence 
of MRSA infections it is estimated that 20,000 deaths occur annually [168]. 
Unfortunately, current problems associated with drug-resistant microbes extend far 
beyond Gram-positive bacteria such as MRSA. Perhaps even more distressing is the 
rapidly increasing antibiotic-resistance of Gram-negative bacteria, which was already 
suffering from inadequate treatments [169].  
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Considering that people afflicted with microbial infections generally receive treatment 
within hospitals, it should come as no surprise that nosocomial infections are becoming 
increasingly problematic for all patients regardless of malady [170].  Nowhere is this 
more evident than with post-operative infections. The introduction of drug-resistant 
bacteria during surgical procedures is thought to be the primary reason for complications. 
More specifically, bacteria easily colonize the surfaces of tissues and surgical devices 
(implants, orthopedics, catheters, etc.), and subsequently form biofilms. Bacterial 
biofilms consist of bacteria and self-secreted extracellular polymeric substances (EPS) 
[127] and are extremely resistant to conventional antibiotics mainly due to resistant gene 
expression in bacteria, limited diffusion and inactivation of antibiotics in EPS [171-173]. 
Biofilm formation is one of the leading causes of the surgical device implantation failure 
[129-133]. In addition, bacterial biofilms make wound management and healing very 
difficult [134]. Due to the insufficiency of standard antibiotic treatments, new approaches 
for preventing and treating drug-resistant infections need to be continually investigated.  
 
Eukaryotic organisms have demonstrated an incredible ability to selectively target 
microbial infections without promoting rapid resistance development. Fundamental to 
this defense is the deployment of host defense peptides (HDPs) which utilize charge and 
facial amphiphilicity [174-177]. Through electrostatic interactions positively charged 
HDPs are attracted to the bacterial cell surface, followed by inserting into the cell 
membrane after recruiting additional peptide molecules, thus disintegrating the cell 
membrane and eventually lysing the cell. This discovery has led to cutting edge research 
into the development of soluble self-assembling synthetic cationic polymers designed to 
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mimic the HDP structure and action [178, 179].  However, application of such materials 
for localized function (such as placement on a skin infection) becomes problematic 
because of their rapid solubilization and subsequent removal. Therefore, there is a critical 
need to develop an antimicrobial material that has a low modulus, is readily remoldable 
and is conformable to a wide variety of surfaces and substrates. 
 
Antimicrobial hydrogels are envisioned to be an integral weapon for combating drug-
resistant infections. Since they exhibit many of the characteristics of water soluble 
polymers without being freely dissolved, such materials can remain in place under 
physiological conditions while still demonstrating antimicrobial activity. These attributes 
make them ideal for applications in wound healing, implant and catheter coatings, skin 
infections or even orifice barriers (such as placement into the nares for decolonization of 
MRSA). Several antimicrobial hydrogels including quaternized ammonium chitosan-
graft-poly(ethylene glycol) methacrylate [180] or epsilon-poly-L-lysine-graft-
methacrylamide (EPL-MA) [181] polyelectrolyte complex (PEC) hydrogel comprising 
chitosan as the cationic polyelectrolyte and co-poly(glutamic acid) (co-PGA) [182] and 
self-assembled peptide hydrogels [183] were reported with broad-spectrum activity. 
However, most of them were formed based on chitosan, a material that is extracted from 
crab shell, can cause immunogenicity and varies from batch to batch in quality and 
molecular size, or produced from expansive peptides. Therefore, there is a pressing need 
to develop antimicrobial hydrogels from synthetic, cost-effective and biodegradable 
materials with well-defined molecular structure. It must also be moldable/processable 
allowing in situ applications. This behavior is exemplified by attributes such as 
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physically cross-linked gels for drug delivery [184, 185] and/or stimuli responsiveness 
(pH, temperature, radiation, etc) [186-189] facilitating gel localization without 
compromising material properties. Furthermore, the antimicrobial hydrogel must also be 
stable and active for the duration of its purpose. However, upon completion of its 
intended use it should undergo natural biological remediation. With the high volume of 
poorly degradable single use healthcare items such as bandages, catheters, stents and 
many others already destined for landfills, the problem would be exaggerated by the 
addition of antimicrobial material that destroys bacteria and fungi responsible for slow 
landfill degradation.   
 
Among biofilm-associated diseases, fungal keratitis is a leading cause of ocular morbidity 
worldwide and it is also a major eye disease in Asia and can cause sight loss [190]. Risk 
factors include epithelial abrasions as a result of contact lenses wearing [191], systemic 
or topical usage of corticosteroids and atopic diseases [192]. Candida albicans is one of 
the most frequently isolated pathogens [193]. Treatment for ocular fungal keratitis 
remains problematic partly because of the lack of effective therapeutical agents against 
fungal biofilms and partly due to the shortage of routine test of fungal isolates in the 
laboratory. Current antibiotics in clinic use include azole compounds such as 
voriconazole and polyenes such as Amphotericin B. Azole can be administered both 
intravenously and orally. Common side effects include reversible disturbance of vision, 
skin rashes and hepatic enzyme level elevation [194, 195]. Moreover, azoles are unstable 
for topical applications as eye drop [196]. On the other hand, usage of polyenes is largely 
limited due to their poor permeability through intact epithelium, stability and high 
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toxicity [197, 198]. Therefore, hydrogel with cationic polymer incorporated serves as an 
alternative and effective approach to treat fungal keratitis. By providing locally 
administration of antimicrobial polymeric macromolecules, hydrogels with low toxicity 
and high biocompatibility are able to remove biofilm without developing drug resistant 
bacteria to overcome the problems associated with the usage of common antimicrobial 
agents.  
 
Herein, we describe a simple yet effective approach to generating charged hydrogels 
using non-covalent interactions to overcome the issues that existing antimicrobial 
hydrogels have. More specifically, we report a stimulus-responsive antimicrobial gel 
formed from stereocomplexes of biodegradable poly(L-lactide)-b-poly(ethylene glycol)-
b-poly(L-lactide) (PLLA-PEG-PLLA) and a charged biodegradable polycarbonate 
triblock polymer (i.e. PDLA-CPC-PDLA). The stereocomplexes were found to exist as 
soluble micelles at room temperature in aqueous solution, however, upon heating to 
physiological temperature (~37C) gel-like materials with distinctive supramolecular 
fiber/ribbon-like structures and shear-thinning behavior were formed. This drastic change 
in material properties was also accompanied by a large increase in antimicrobial activity 
which encompassed Gram-positive/Gram-negative bacteria and fungi, and drastically 
disrupted microbial biofilms. 
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4.2 Materials and methods 
4.2.1 Materials 
Staphylococcus aureus (ATCC 6538), Escherichia coli (ATCC 25922) and Candida 
albicans (ATCC 10231) were obtained from ATCC. Human dermal fibroblast (HDF) was 
obtained from ATCC. Dulbecco’s Modified Eagle Medium (DMEM), fetal bovine serum 
(FBS), sodium pyruvate, penicillin-streptomycin were all purchased from Invitrogen 
(U.S.A). Tryptic soy broth (TSB) powder and yeast mould broth (YMB) powder were 
purchased from BD Diagnostics (Singapore) and used to prepare the microbial broths 
according to the manufacturer’s instructions. Phosphate-buffered saline (PBS) at 10 × 
concentration was obtained from 1st BASE Pte Ltd (Singapore) and used after dilution to 
the desired concentration. Ethanol (analytical grade, 99%) and Glutaraldehyde (Synthetic 
grade, 50% in H2O) were purchased from Sigma-Aldrich (Singapore) and used as 
received. Rat red blood cells were obtained from Animal Holding Units of the 
Biomedical Research Centers (Singapore). Lotrafilcon A contact lenses were purchased 
from CIBA Vision with a power of +1.00 diopters. Cyclophosphamide, 1-heptanol and 
commercial antifungal agent Amphotericin B were obtained from Sigma-Aldrich 
(Switzerland). Tetracaine hydrochloride eye drops was obtained from Bausch & Lomb 
Pharmaceuticsa (Florida).  
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4.2.2 Polymer synthesis and characterization 
4.2.2.1 Polymer synthesis 
Polymers for hydrogel formation, PLLA-PEG-PLLA, PDLA-PEG-PDLA and PDLA-
CPC-PDLA, were synthesized by Dr. James L. Hedrick in IBM, Almaden Research 
Center, U.S. Detailed synthesis and characterization of the polymers is shown in 
Appendix C. 
 
4.2.2.2 Particle size and zeta potential 
Polymer solutions were prepared in DI water at 1 mg/ml using PDLA-CPC-PDLA or 
PLLA-PEG-PLLA and PDLA-CPC-PDLA stereocomplex mixture in a 1:1 molar ratio of 
PDLA and PLLA. The polymer solutions were equilibrated for 1 hour. Particle size of the 
particles was measured using a Zetasizer (3000 HAS, Malvern Instrument, U.K.) at 25 C. 
Each measurement was repeated three times. An average value was obtained from the 
three measurements. 
 
4.2.2.3 Minimal inhibitory concentration (MIC) determination 
The bacteria were grown in tryptic soy broth at 37 C and yeast was cultured in yeast 
mould broth at 24 C. The MICs of the polymers were measured using a broth 
microdilution method. Briefly, polymer stock solution was prepared by dissolving 25 mg 
polymer in 100 µL phosphate-buffered saline (PBS, pH 7.4) followed by a serial dilution 
into various concentrations using growth media. Subsequently, 90 µL of fresh growth 
media and 10 µL of polymer solution were added to each well. 100 µL of microorganism 
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solution at a concentration, which gave an optical density reading of ~0.1 at 600 nm, was 
added into each well. The cell cultures were then incubated for 8 hours and the optical 
density was monitored at 2 hours intervals. The MIC was taken at the concentration, at 
which no growth was observed. Broth containing cells alone was used as control.  
 
4.2.2.4 Hemolysis assays 
Fresh mouse red blood cells were washed with PBS for three times. 100 µL of red blood 
cell suspension in PBS (4% in volume) was placed in each well of 96-well plates and 100 
µL of polymer solution with various concentrations was added to each well. The plates 
were incubated at 37 C for 1 hour, followed by centrifuge at 1000g for 5 min. 100 µL of 
supernatant were transferred to 96-well plates, and hemoglobin release was monitored at 
576 nm using a microplate reader (Bio-Teck Instruments, Inc). The red blood cell 
suspension in PBS was used as negative control. Absorbance of wells with red blood 
cells lysed with 0.5% Triton X-100 was taken as positive control of 100% haemolysis. 












4.2.2.5 Cytotoxicity assay 
The cytotoxicity of the cationic polymers against human dermal fibroblast (HDF) was 
studied by standard MTT assay in triplicates. Briefly, HDF cells were seeded onto 96-
well plates at density of 10 000 cells per well and allow to attach overnight before 
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treatment. The cells were then incubated with polymer containing growth media 
comprising of 10 µL cationic polymers and 100 µL fresh growth media for 12 hours at 37 
C. Subsequently, 100 µL of fresh growth media and 10 µL MTT solution (5mg/mL in 
PBS) were added to each well and incubated for 4 hours at 37 C.  Resultant formazan 
crystals formed were solubilized using 200 µL DMSO after removal of the growth media. 
An aliquot of 100 µL was taken from each well and transferred to a fresh 96-well plate. 
The plates were then assayed at wavelength of 550 nm and 690 nm using a microplate 
reader (Tecan, Switzerland). Percentage of cell viability was expressed as [(A550-A690) 
sample/ (A550-A690) control] ×100%in the wells without cationic polymers.  
 
4.2.3 Hydrogel formation and characterization 
4.2.3.1 Hydrogel formation 
In the preparation of a typical hydrogel, PLLA-PEG-PLLA (3.5 mg, 0.45 mol), PDLA-
CPC-PDLA (0.5 mg, 0.03 mol) and PDLA-PEG-PDLA (2.6 mg, 0.33 mol) were 
dissolved in 50 l DI water. The resultant hydrogel was kept in a 37˚C incubator for 5 
hours. It should be mentioned that the molar ratio of PLLA to PDLA group was 1.0, and 
the final PLLA-PEG-PLLA concentration was 7 (w/v) %.  
 
4.2.3.2 Differential scanning calorimetry 
Differential scanning calorimetry (DSC) was performed using a TA Differential Scanning 
Calorimeter 1000 that was calibrated using high purity indium. Melting points were 
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determined from the second scan at a heating rate of 5ºC/min following slow cooling (to 
remove the influence of thermal history) at a heating rate of 3ºC/min. 
 
4.2.3.3 X-ray diffraction analysis 
X-ray diffraction analysis was performed on a PANalytical X-ray diffractometer (X’pert 
PRO) with Cu Kα radiation at 0.154nm. The hydrogels were lyophilized and mounted 
onto zero-background XRD holders. 
 
4.2.3.4 Rheology 
Rheology experiments were performed at room temperature (25 ± 2C) using a control-
strain rheometer (ARES G2, U.S.A). The dynamic storage modulus (G) was examined as 
a function of frequency from 0.1 to 50 rad/s. The measurements were carried out at strain 
amplitude (γ) of 5 % to ensure the linearity of viscoelasticity. Viscosity of the hydrogel 
was examined as a function of shear rate from 0.1 to 1 1/s.  
 
4.2.3.5 Fiber observation under optical microscopy, SEM, TEM 
The morphologies of the hydrogel fibers were observed under Olympus microscope 1×71 
with DP 70 camera (Japan). To prepare the sample, the hydrogel were prepared as 
described in section 4.2.3.1 and diluted to 5 mg/ml after incubating for 5 hours. 20 μL 
fiber solution was placed into a 96-well plate and observed under the microscope. 
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The morphologies of the hydrogel fibers and microorganisms after treatment with 
hydrogels were observed using a field emission SEM (JEOL JSM-7400F) operated at an 
accelerating voltage of 10 keV. For hydrogel fibers, the hydrogel were prepared as 
described in section 4.2.3.1 and diluted to 5 mg/ml after incubating for 5 hours. 20 μL of 
the fiber solution was placed on a copper tape, and air-dried at room temperature (25 ± 
2C). The copper tape was mounted on metal holders and vacuum coated with a platinum 
layer before SEM examination 
 
Fiber morphology was also observed under a FEI Tecnai G
2
 F20 transmission electron 
microscope (TEM) using an acceleration voltage of 200 KeV. To prepare the TEM 
sample, the hydrogel were prepared as described in section 4.2.3.1 and diluted to 5 mg/ml 
after incubating for 5 hours. 5 μL  of the fiber solution was placed on a plasma treated 
formcar/carbon-coated 200 mesh copper grid and left to dry under room temperature (25 
± 2C) prior to TEM observation. 
 
4.2.4 Antimicrobial activities in vitro 
Hydrogels with and without cationic polymer were prepared as described in section 
4.2.3.1. 30 µL of microorganism solution at a concentration, which gave an optical 
density reading of ~0.1 at 600 nm, was then added onto each hydrogel. Hydrogel without 
cationic polymer and DI water (pH 7.4) were used as negative controls. The cell hydrogel 
construct were then incubated for 8 hours and the optical density was monitored at 2 
hours intervals. Stereocomplex cationic hydrogels were tested against gram-negative 
bacteria E.coli, gram-positive bateria S.aureus and fungus C. Albicans as well as various 
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clinically isolated microbes, including methicillinresistant S. aureus (MRSA, gram-
positive), vancomycinresistant enterococci (VRE, gram-positive), P. aeruginosa (gram-
negative), A. baumannii (gram-negative, resistant to most antibiotics), K. pneumoniae 
(gram-negative, resistant to carbapenem), and C. neoformans. 
 
4.2.4.1 Killing efficiency 
After 8 hours incubation, 20 µl of the microorganism with or without dilution using 
medium was taken out from the hydrogel and streaked on the agar plate. The agar plates 
were inverted and incubated in a 37 C incubator for 24 hours. The number of colony 








4.2.4.2 SEM observation 
The microorganisms grown in DI water alone or incubated on the hydrogel with or 
without cationic polymer were harvested by centrifuging at 4000 rpm for 5 minutes. They 
were washed with phosphate-buffered saline (PBS) and then fixed in PBS containing 5% 
formaldehyde for half an hour. The cells were further washed with DI water, followed by 
dehydration using a series of ethanol washes and drying at room temperature (25 ± 2C). 
The cell sample was placed on copper tape, which was mounted onto aluminum stud, and 
coated with platinum prior to SEM analysis. 
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4.2.4.3 Drug resistance stimulation study 
Drug resistance was studied by repeatedly exposing microbes to antimicrobial agents at 
sub MIC concentration. In this study, we tested E. coli as a model microorganism. With 
the microdilution method mentioned in section 4.2.2.3, MIC of gentamicin, ciprofloxacin 
was monitored for consecutive 10 passages. At passage n, bacterial treated at sub-MIC 
(1/4 MIC at that specific passage) were revived and re-grown for subsequent MIC test 
(passage n+1). By monitoring the changes in MIC, MIC at passage n (MICn) was 
normalized to that of passage 1 (MIC1) and drug resistance development was studied. 
Two conventional antibiotics with different growth inhibitory mechanisms ciprofloxacin 
(fluoroquinolone antibiotics) and gentamicin (aminoglycoside antibiotics) were chosen in 
comparison with hydrogel (Gel 1). 
4.2.5 Antibiofilm activities in vitro 
4.2.5.1 Biofilm growth on 96 well plate 
S. aureus (ATCC 6538), E. coli (ATCC 25922) and C. albicans (ATCC 10231) were 
obtained from ATCC and clinically isolated methicillin-resistant Staphylcoccus aureus 
(MRSA) was obtained from a local hospital [199]. The bacteria were grown overnight in 
tryptic soy broth (TSB) at 37 C and diluted in TSB to 1×106 cells/ml before use. 100 μl 
of the diluted cell suspension were then inoculated into each well of 96-well plate and 
cultured for 7 days. PBS was added to wash off the planktonic and loosely adhered cells 
before fresh medium were changed everyday.  
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4.2.5.2 Biomass assay 
Biomass of the biofilm was analyzed using crystal violet staining assay after incubating 
the biofilm with hydrogels for 24 hours [200]. After removal of culture medium, the 
formed biofilm was gently washed with PBS three times to remove the planktonic cells. 
100 μl of methanol was added to fix the biomass for 15 min, followed by 100 μl of 
crystal violet staining (0.1 w/v %) for 10 min. Excess of crystal violet was washed off 
thoroughly with DI water. The remaining crystal violet bound with the biofilm was 
extract by 33% glacial acetic acid and the absorbance was measured at 570 nm with a 
microplate reader (Tecan, Switzerland). The results were expressed as a percentage of the 
cell viability without treatment. 
 
4.2.5.3 XTT assay 
XTT assay was used for quantification of viable cells in the biofilms after the incubation 
of biofilm with hydrogels for 24 hours. XTT assay is based on the reduction of 2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide 
(XTT) in the metabolically active microbial cells to a water soluble formazan [201]. 
Briefly, XTT solution (1 mg/mL) was prepared using PBS and filtered with 0.22 μm pore 
size filter. Menadione solution (0.4mM) was prepared and mixed with XTT solution at a 
ratio of 1:5 by volume right before each assay. At the end of treatment, medium was 
removed and biofilm were carefully washed with PBS three times to remove planktonic 
cells. 120 μl of PBS and 14.4 μl of the XTT-menadione solution was added to each well 
and incubated for 3 hours. An aliquot of 100 µL was then taken and transferred to a fresh 
96-well plate. The plates were then assayed at 490 nm with a microplate reader (Tecan, 
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Switzerland). The results were expressed as a percentage of the cell viability without 
treatment. 
 
4.2.5.4 SEM observation 
The morphologies of the biofilm treated with control, control gel, gel 1 and gel 2 were 
observed using a field emission SEM (JEOL JSM-7400F) operated at an accelerating 
voltage of 10 keV. After incubation for 24 hours, the biofilms were gently washed with 
phosphate-buffered saline (PBS) once and then fixed in PBS containing 5% 
formaldehyde for half an hour. The cells were further washed with DI water, followed by 
dehydration using a series of ethanol washes and drying at room temperature (25 ± 2C). 
The cell sample was placed on copper tape, which was mounted onto aluminum stud, and 
coated with platinum prior to SEM analyses. 
 
4.2.6 Antibiofilm activities in vivo 
4.2.6.1 Contact lens-associated keratitis model 
4.2.6.1.1 Biofilm growth on contact lenses 
The contact lens were washed once with 1×PBS and punched into small pieces of 2 mm 
in diameter before incubating at 37 ºC in YM broth overnight. To grow Candida albicans 
biofilm, the contact lenses were cultured in 6 well plates with 4 mL yeast suspension (10
6
 
CFU/mL) and incubated at 22 ºC for 5 hours. After incubation, the contact lenses were 
gently washed with PBS to remove the planktonic cells and immersed in fresh YM broth 
for 4 days at 22 ºC with shaking at 100 rpm.  
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4.2.6.1.2 Mice source 
Adult C57BL/6 mice (6-8 weeks, 18-22 g) were used for animal studies. 6 mice were 
housed in individual cage under standard condition. All eyes were examined to avoid any 
ocular pathology before experiment initiation. Experiment protocol was done with 
approval of the Institutional Animal Care and Use Committee of Biological Resource 
Centre, A-STAR, Singapore. 
 
4.2.6.1.3 Keratitis model initiation 
Black mouse keratitis model was established as our collaborator did [202, 203]. Briefly, 
the mice were firstly immune suppressed by cyclophosphamide (180 g/kg) for 2 days (sc) 
and anaesthetized by ketamine (150mg/kg) and xylazine (10mg/mL), I.P., followed by an 
additional topical anesthetic administration of 0.5% tetracaine hydrochloride eye drops 
before surgery. A 1 mm filter paper disk soaked with 99% of 1-heptanol was placed on 
the center of the cornea for 40 s and the cornea epithelium was removed atraumatically. 
After rinsing the eyes with PBS to remove remaining traces of 1-heptanol, a 2 mm 
contact lens with Candida albicans biofilm was then placed on the denuded cornea 
surface. The eye lids were closed with silk sutures in order to keep the contact lenses 
inside the eyes. After infection for 18 hours, eye ulcer with a leathery, tough and raised 
surface was observed due to fungi infection on the eyeball. A disease grading system 
from 0 (no disease) to 4 (severe disease) was established to evaluate model efficacy.   
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4.2.6.2 Biofilm susceptibility 
The treatment was adopted from a study of Amphotericin B [204]. The infected mice 
were randomly assigned into 3 groups (saline group, 250 µg/mL Amphotericin B and 
hydrogel group, 8 mice in each group) with comparable median disease grades. After 
infection of 18 hours, the silk sutures and contact lenses were removed, 10 μL of eye 
drop was then administered to both eyes, and uninfected eyes with intact corneal 
epithelium were used as control. Topical administration was repeated at hourly interval 
for 8 hours. Photos were taken before and after the treatment. All mice were sacrificed 
after the last administration of eye drop. The treated eyes were collected immediately; 
three of them were fixed in 4% paraformaldehyde for histology assay and remaining five 
were collected for quantitative fungi recovery assay.  
 
4.2.6.2.1 Fungi recovery assay 
The eyeball was gently washed with PBS and homogenized in 3 mL PBS ground on ice 
for 6 cycles of 10 s using a tissue ruptor. Yeast cells were detached in PBS by 
ultrasonication for 3 min. After a serial dilution, 20 μL sampling aliquots were streak on 
LB agar plates and incubated at 22 ºC for 48 hours before counting the colony forming 
unit (CFU). The percentage of fungi recovery was expressed as the number of CFU 
revived from treatment groups as compare to those revived from control group to 




Histological assay was utilized to evaluate the in vivo acute toxicity of the hydrogels after 
topical administration. Briefly, the fixed corneal were embedded in paraffin and 
sectioned to 5 μm. The resulted sections were stained using hematoxylin eosin, 
Groccott’s methenamine silver and periodic acid Schiff reagents by standard protocol. 
The extent of stromal infiltration induced by fungal elements was examined by light 
microscopy ar the central corneal sections of each eye. Maximal penetration depth and 
total hyphal area in a defined area were measured. 
 
4.2.7 Statistical analysis 
All data are presented as mean ± SD. The statistical significance of the data was 
evaluated by two- tailed Student's t-Test. P<0.05 was considered statistically significant. 
 
4.3 Results and discussions 
4.3.1 Polymer synthesis and characterization 
4.3.1.1 Polymer synthesis 
Polymers for hydrogel formation, PLLA-PEG-PLLA, PDLA-PEG-PLLA and PDLA-
CPC-PDLA, were synthesized by Dr. James L. Hedrick in IBM, Almaden Research 
Center, U.S using organocatalyzed ring opening polymerization (ROP) techniques [205-
208]. The PLLA-PEG-PLLA triblock copolymers synthesized have very narrow 
molecular weight distributions (Scheme 4.1 A). Three separate PDLA-CPC-PDLA 
polymer compositions of different block length were studied; 1000-6000-1000 (PC1), 
2000-13000-2000 (PC2) and 1500-6000-1500 (PC3) Scheme 4.1 B.  
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X = Cl or Br
 
PDLA-CPC-PDLA 
PC1 = PDLA1k-CPC6k-PDLA1k 
PC2 = PDLA2k-CPC13k-PDLA2k 
PC3 = PDLA1.5k-CPC6k-PDLA1.5k 
 
Scheme 4.1 Chemical structure of P(D/L)LA-PEG-P(D/L)LA (A) and cationic polymer 
PDLA-CPC-PDLA (B). Three separate PDLA-CPC-PDLA polymer compositions of 
different block length were synthesized; 1000-6000-1000 (PC1), 2000-13000-2000 (PC2) 
and 1500-6000-1500 (PC3). 
 
4.3.1.2 Particle size and zeta potential 
The utilization of a central cationic block produced water soluble materials, which 
spontaneously formed spherical micelles ranging from 134 to 181 nm in size with zeta 











































Figure 4.1 Particle size and zeta potentials of PDLA-CPC-PDLA copolymers. Polymer 
solutions were prepared in DI water at 1 mg/ml using PDLA-CPC-PDLA and 
equilibrated for 1 hour before measurement. 
 
4.3.1.3 Minimal inhibitory concentration (MIC) determination 
Despite having alkyl ammoniums, no antimicrobial activity was observed for PDLA-
CPC-PDLA at concentrations below 10000 mg/L for all the three cationic polymers in 
solution form (Table 4.1). 
Polymers
Gram-positive Gram-negative
S. aureus E. coli
PC1 (PDLA1k-CPC6k-PDLA1k) 10000 10000
PC2 (PDLA2k-CPC13k-PDLA2k) > 25000 > 25000
PC3 (PDLA1.5k-CPC6k-PDLA1.5k) > 25000 > 25000  
Table 4.1 Minimum inhibitory concentrations (MICs) of cationic PDLA-CPC-PDLA 
triblock copolymers. The MICs of the polymers were measured using a broth 
microdilution method. 
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4.3.1.4 Hemolysis and cytotoxicity assays 
The cationic triblock polymers were further tested for cytotoxicity against rat red blood 
cells and human dermal fibroblasts (HDF).  It was found that PC2 was the least toxic 
among the three copolymers, and no hemolysis was observed for PC2 up to a 
concentration of 25,000 mg/L (Figure 4.2) while maintaining HDF cell viability above 























Figure 4.2 Hemolytic activity of cationic polycarbonate copolymers. Fresh mouse red 
blood cells were incubated with polymer solution for 1 hour. The red blood cell 

























Figure 4.3 Viability of primary human dermal fibroblasts after incubation with cationic 
polycarbonate copolymers at various concentrations for 12 hours.  
 
4.3.2 Hydrogel formation and characterization 
4.3.2.1 Hydrogel formation 
PDLA-CPC-PDLA (PC2) was then incorporated into PLLA-PEG-PLLA (0.85k-6k-0.85k) 
and PDLA-PEG-PDLA (1k-6k-1k) gels at different contents via stereocomplexation at 
37C with a total concentration of 13.2% w/v to impart antimicrobial function. Three 
different gel compositions where studied; Gel 1 (PLLA-PEG-PLLA, PDLA-PC-PDLA 
and PDLA-PEG-PDLA at 1:0.15:0.85), Gel 2 (PLLA-PEG-PLLA, PDLA-PC-PDLA and 
PDLA-PEG-PDLA at 1:0.3:0.7) and Gel 3 (PLLA-PEG-PLLA and PDLA-PC-PDLA at 
1:1). The molar ratio of PLLA to PDLA was kept at 1:1. Upon dissolution in water, the 
PEG-based copolymers and their mixture having the opposite stereochemistry formed 
clear solutions (Scheme 4.2 b and d). Kimura et al. reported two distinctive gel processes 




C and believed that the gel formation resulted 
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from the crystallization of collapsed PLA domains in water [209]. Similar to his findings, 
we observed a cloud point and gelation upon heating the polymer solution above 37
o
C 















Scheme 4.2 Chemical structures of PLLA-PEG-PLLA and PDLA-CPC-PDLA (a) and 
pictures of 10 wt% solution at 25 ºC (b) and at 37 ºC (c). At 25 ºC the solution is clear 
fluid and each polymer forms flower-type micelles in aqueous environment (d). Upon 
heating at 37 ºC for 30 min, the solution turns into opaque gel based on stereocomplex 
formation between enantiomeric pure polylactide segments in the micelle cores (e).  
4.3.2.2 Differential scanning calorimetry 
Interestingly, this supramolecular gel did not show a melting point associated with the 
PLA component (Figure 4.4 B). Whereas for P(D/L)LA-PEG-P(D/L)LA of long  
P(D/L)LA block length and resulted stereocomplex, a melting point shift from 114°C to 
174°C was clearly observed due to the stereocomplexation (Figure 4.4 A). Similar 
finding was reported by O’Reily that PEG-PLA block polymer micelles crystallized 
adjacent lactide blocks to form high aspect ratio nanostructures [210]. 
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Figure 4.4 DSC of stereocomplexes. A. Stereocomplex of long PLA segment: a. PDLA-
PEG-PDLA (2k-6k-2k), b. PLLA-PEG-PLLA (2k-6k-2k), c. PDLA-PEG-PDLA (2k-6k-
2k) : PLLA-PEG-PLLA (2k-6k-2k) at 1:1 molar ratio; B. Stereocomplex of short PLA 
segment: d. PLLA-PEG-PLLA (0.85k-6k-0.85k), e. PDLA-PEG-PDLA (1k-6k-1k) and f. 
PDLA-PEG-PDLA (0.85k-6k-0.85k) : PLLA-PEG-PLLA (1k-6k-1k) at 1:1 molar ratio 
 
4.3.2.3 X-ray diffraction analysis 
X-ray diffraction (XRD) patterns of individual polymer and stereocomplexes were tested 
to further confirm the stereocomplexation. As shown in Figure 4.5, pure PLLA shows 
two intense peaks at 2θ of 16.9° and 19.3°. The PLLA-PEG-PLLA shows both the peaks 
of PEG at 19.4° and 23.6° and those pronounced signals due to PLA stereocomplex 



































Figure 4.5 Wide-angle X-ray diffraction patterns of control polymers: a. PLLA-PEG-
PLLA 850-6000-850 , b. PLLA 2000) and c. control Gel (PLLA-PEG-PLLA and PDLA-
PEG-PDLA at 1:1 molar ratio), d. Gel 1 (PLLA-PEG-PLLA, (PDLA-PC-PDLA and 
PDLA-PEG-PDLA at 1:0.15:0.85), e. Gel 2 (PLLA-PEG-PLLA, PDLA-PC-PDLA and 
PDLA-PEG-PDLA at 1:0.3:0.7) and f. Gel 3 (PLLA-PEG-PLLA and PDLA-PC-PDLA 
at 1:1). The gels were formed at 7% w/v and freeze dried for experiment. 
 
4.3.2.4 Rheology 
Copolymers having lower PLA block lengths (e.g. Mn = 850 and 1000 g/mol), required 
for water dispersion without use of an organic solvent, formed opaque, low modulus and 
viscous solutions (13.2% w/v aqueous solutions) after incubation at 37
 o
C for 5 hours. As 
shown in Figure 4.6, storage modulus of stereocomplex was much higher than either of 
the isomer alone, indicating hydrogel formation. In addition, storage modulus of the 
hydrogel decreased as the incorporation of PC2 increased, depending on the amount of 
PC2 present in the system. It was reasoned that the fiber-like assemblies were forming 
through partial crystallization of the lactide domains[212], which reinforced the gel, 





























Figure 4.6 Storage modulus of individual polymer solutions and stereocomplex gels. 
Polymer concentration: 13.2% w/v. The dynamic storage modulus (G) was examined as 
a function of frequency from 0.1 to 50 rad/s. The measurements were carried out at strain 
amplitude (γ) of 5% to ensure the linearity of viscoelasticity 
 
Furthermore, regardless of PC2 content, modulus was found to increase with longer 
annealing times, supporting the idea of refining crystallization within the lactide blocks 
(Figure 4.7). The moduli were low for all three cationic gels (Gel 1, 2 and 3), reflecting 
the non-covalent nature of the gel-forming reacton. As such the gels were readily 
remoldable, and showed a significant drop in viscosity with increasing shear rate (Figure 
4.8), indicating a unique ability to shear-thin. This likely resulted from the dynamic 
nature of the gel-forming reaction and/or the alignment for the supramolecular features. 
This unique attribute is thought to significantly facilitate the ease of deposition for 


































Figure 4.7 Rheology changes of the cationic hydrogels as a function of annealing time. 
Hydrogels were incubated in 37 ºC incubator and rheology of the hydrogels was 

























Figure 4.8 Viscosity of representative hydrogel as a function of sheer rate from 0.1 to 1 





4.3.2.5 Fiber observation under light microscope, SEM and TEM 
Imaging of the PLLA-PEG-PLLA with an optical microscope showed an abundance of 
fiber-like nanostructures, whereas PDLA-PEG-PDLA formed far fewer fiber-like 
assemblies (Figure 4.9). After combining PLLA-PEG-PLA with PDLA-PEG-PDLA after 
incubation 37
 o
C for 5 hours, short fibers were formed (Figures 4.9 and 4.10), but it was 
accompanied by gel formation and a much higher modulus than either of the isomers 
alone (Figure 4.6). Fiber length was determined by counting and measuring 100 fibers at 
5 different areas of each sample.  
 
Figure 4.9 Optical micrographs of individual polymers and stereocomplex gels. Polymer 





























Figure 4.10 Fiber length of individual polymers and stereocomplex gels. Fiber length 
was determined by counting and measuring 100 fibers at 5 different areas of each sample. 
 
Using transmission and scanning electron microscopies, major morphological changes 
were observed for the gels formed with stoichiometric equivalents of PDLA-CPC-PDLA 
and PLLA-PEG-PLLA (Gel 3) relative to the control gel prepared from PLLA-PEG-
PLA/PDLA-PEG-PDLA (Gel 3 in Figure 4.11 and 4.12). Nonetheless, numerous fibers 
with similar length were also seen in PLLA-PEG-PLA/PDLA-PEG-PDLA/PC2 gels with 
lower amounts of PC2 (Gel 1 and Gel 2 in Figure 4.11 and 4.12). 
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Figure 4.11 SEM images of Control Gel (PLLA-PEG-PLLA and PDLA-PEG-PDLA at 
1:1 molar ratio), Gel 1 (PLLA-PEG-PLLA, (PDLA-PC-PDLA and PDLA-PEG-PDLA at 
1:0.15:0.85), Gel 2 (PLLA-PEG-PLLA, PDLA-PC-PDLA and PDLA-PEG-PDLA at 
1:0.3:0.7) and Gel 3 (PLLA-PEG-PLLA and PDLA-PC-PDLA at 1:1).  
 
Figure 4.12 TEM images of Control Gel (PLLA-PEG-PLLA and PDLA-PEG-PDLA at 
1:1 molar ratio), Gel 1 (PLLA-PEG-PLLA, (PDLA-PC-PDLA and PDLA-PEG-PDLA at 
1:0.15:0.85), Gel 2 (PLLA-PEG-PLLA, PDLA-PC-PDLA and PDLA-PEG-PDLA at 
1:0.3:0.7) and Gel 3 (PLLA-PEG-PLLA and PDLA-PC-PDLA at 1:1).  
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4.3.3 Antimicrobial activities in vitro 
4.3.3.1 Killing efficiency 
The antimicrobial activities of gel complexes were evaluated against various pathogenic 
microbes including S. aureus (Gram-positive), E. coli (Gram-negative) and C. albicans 
(fungus). PC2 was used at concentrations below 25,000 mg/L to form antimicrobial gels 
as it did not induce significant hemolysis and cytotoxicity at this concentration (Figures 
4.2 and 4.3). The control gel formed from PLLA-PEG-PLLA with PDLA-PEG-PDLA 
and PC2 alone at 25000 mg/L showed no activity (Figure 4.13, Table 4.1). In sharp 
contrast, the stereocomplex gels made from PLLA-PEG-PLLA, PC2 and PDLA-PEG-
PDLA at 1:0.15:0.85 molar ratio (i.e. Gel 1, PC2=10000 mg/L) completely suppressed 
bacterial growth and killed the bacteria (i.e. S. aureus and E. coli) at ~100% efficiency. A 
gel with an increased amount of PC2 to 20000 mg/L (i.e. Gel 2, ratio=1:0.3:0.7) was 






























































































































Figure 4.13 Antimicrobial activities of cationic hydrogels against various microbes: 
Growth inhibition of a: S. aureus (Gram-negative bacteria) (a); E. coli (Gram-negative 
bacteria) (b) and C. albicans (yeast) (c); % killing efficiency of different microbes (Gel 1 
for S. aureus and E. coli, Gel 2 for C. albicans) (d). The number of colony forming unit 
(CFU) was recovered and counted in Killing efficiency= (cell count of control-survivor 
count on cationic hydrogel)/cell count of control×100. 
 
In order to demonstrate the clinical potential of these antimicrobial hydrogels, they were 
tested against clinically isolated microbes such as methicillin-resistant S. aureus (MRSA, 
Gram-positive), vancomycin-resistant enterococci (VRE, Gram-positive), A. baumannii 
(Gram-negative, resistant to most antibiotics), K. pneumoniae (Gram-negative, resistant 
to carbapenem) and C. neoformans (fungus). The hydrogels were found to completely 
inhibit growth and showed a near perfect killing efficiency on all cell lines tested (Figure 





















Figure 4.14 Killing efficiency of stereocomplex cationic hydrogels against various 
clinically isolated microbes, including methicillinresistant S. aureus (MRSA, gram-
positive), vancomycinresistant enterococci (VRE, gram-positive), P. aeruginosa (gram-
negative), A. baumannii (gram-negative, resistant to most antibiotics), K. pneumoniae 
(gram-negative, resistant to carbapenem), and C. neoformans. 
 
4.3.3.2 Antimicrobial mechanism 
The antimicrobial mechanism was determined to be cell wall/membrane lysis. This 
determination was supported by morphological changes of S. aureus, E. coli and C. 
albicans after incubation with the antimicrobial gels for 2 hrs. As shown in Figure 4.15, 
the untreated microbial cells or cells treated with the control gel remained smooth and in 
round (S. aureus and C. albicans) or rod-like (E. coli) shapes. In sharp contrast, cellular 
deformation and rough surfaces could clearly be seen after treatment with an 
antimicrobial gel for 2 hrs. Additionally, lysed cells and debris were also observed in the 
treated microbes. In the case of E. coli, numerous vesicle-like structures were formed 
presumably from gel-cell membrane integration (white arrows in Figure 4.15 b). Further 
highlighting the catastrophic membrane failure mechanism was the release of cytoplasts 
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in C. albicans after antimicrobial gel exposure (Figure 4.15 c). Based on these 
observations, we hypothesize that the anionic cell surface was associated with cationic 
polycarbonate blocks at many points on the gel surface via electrostatic interaction, 
which might further allow hydrophobic components in the gel to interact with lipid 
domains of cell membrane, thus causing terminal cell damage. Similarly, an “anion 
sponge” model for antimicrobial mechanism of hydrogel was proposed by Peng Li and 
his group [126]. According to this model, anionic microbial membrane was attracted and 
suctioned into the internal nanopores of the cationic hydrogels, disrupting microbial 
membrane integraty and causing microbial cell death.  
 
Figure 4.15 SEM images of S. aureus (a), E. coli (b) and C. albicans (c) before (Control) 
and after incubation with Control Gel, Gel 1 (S. aureus and E. coli), and Gel 2 (C. 




4.3.3.2 Drug resistance stimulation study 
It has been reported that repeated exposure of microbes to antimicrobial agents at 
concentration under their lethal dose contribute to drug resistance development [213]. 
This phenomenon was stimulated by monitoring the MIC of E. coli, survive and re-grow 
from sub-MIC treatment with ciprofloxacin, gentamicin and hydrogel (Gel 1) over 10 
passages. As shown in Figure 4.16, bacterial developed drug resistance against different 
antimicrobial agents at different passages. MIC of E. coli with ciprofloxacin started to 
increase at passage 3 and shoot up to 10 times increase at passage 10 and MIC increase of 
E. coli with gentamicin was observed even at passage 2 and continuously increased 6.7 
times by passage 10. In sharp contrast, no resistance was observed for bacterial treated 
with hydrogel (Gel 1) and killing efficiency was remained as 100% throughout the course 
of treatment. This can be attributed to the different antimicrobial mechanism adopted by 
the various antimicrobial agents. More importantly, we can infer that macromolecular 
antimicrobial agents offer greater advantages over conventional antibiotics in preventing 
drug-resistance development by adopting the membrane disruption mechanism. Same 
observation was reported by Wiradharma et al in microbes treated with macromolecular 
























Figure 4.16 Changes in MIC against different antimicrobial agents upon repeated 
exposure with sub-lethal concentration. E. coli was used as a model microorganism and 
repeatedly exposed to antimicrobial agents at sub MIC concentration. MIC of gentamicin, 
ciprofloxacin and cationic hydrogels was monitored for consecutive 10 passages to 
monitor the MIC changes. 
4.3.4 Antibiofilm activities in vitro 
4.3.4.1 Biomass and XTT assay 
To further investigate the antibiofilm activity of hydrogel complex, biofilm of S. aureus, 
MRSA, E. coli and C. albicans were cultured and formed in 96-well plate for 7 days 
[215]. Stereocomplex hydrogels prepared from PLLA-PEG-PLLA, PC2 and PDLA-PEG-
PDLA at 1:0.15:0.85 molar ratio (i.e. Gel 1, PC2=10000 mg/L) and 1:0.3:0.7 molar ratio 
(i.e. Gel 2, PC2=20000 mg/L) were able to remove more than 60% of biomass (Figure 

























































































































































































































































































































Figure 4.17 Anti-biofilm activities of cationic hydrogels against various microbes: 
biomass reduction (a1-4) and cell viability (b1-4) in S. aureus (1), MRSA (2), E. coli (3) 
and C.albicans (4). Biofilms of different microorganisms were formed for 7 days and 
treated with hydrogels for 24 hours. The results were expressed as a percentage of the cell 
viability without treatment. 
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4.3.4.2 SEM observations 
Biofilm dispersion was further proved by the SEM images of the biofilms before and 
after the treatment (Figure 4.18). Typical biofilm structures were shown in both control 
and control gel group. In sharp contrast, biomass of the biofilm treated with cationic 
hydrogel was significantly decreased. A small portion of cells were left with cell 




Figure 4.18 SEM images of S. aureus (a), MRSA (b), E. coli (c) and C. albicans (d) 
before (Control) and after incubation with Control gel, Gel 1 and Gel 2 for 24 hours. Size 
of the bars: 1 µm; inserted Control and Control gel samples: 1 µm; inserted Gel 1 and Gel 
2 samples: 100 nm. 
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4.3.5 Antibiofilm activities in vivo 
4.3.5.1 Fungal recovery assay 
Candida albicans was recovered from 5 corneas of each group. Compared to the corneas 
of the control group, which normalized to be 100%, fungi recovery of the cornea was 
significantly lower in the Amphotericin B and gel 3 group (P<0.05, Figure 4.19). Photos 
























Figure 4.19 Fungi recovery from cornea of all treatment groups (Control, Amphotericin 
B and gel 3). Data normalized to control group. Fungus were recovered from the eye ball 
and incubated at 22 ºC for 48 hours before counting the colony forming unit (CFU). The 
percentage of fungi recovery was expressed as the number of CFU revived from 
treatment groups as compare to those revived from control group to determine the 
survival of Candida albicans. 
 
4.3.5.2 Histopathology 
Photographs of the infected eyes with keratitis were taken before and after the treatment 
with control group, AMB and antimicrobial hydrogels (Figure 4.20). Significant 
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improvement was observed for the groups treated with AMB and antimicrobial hydrogel 
as compared to control group. Furthermore, the depth of fungal invasion was observed 
after staining (Figure 4.21 A). Compared to the hyphae invasion in control group, both 
AMB and antimicrobial hydrogel reduced the maximal depth of hyphae invasion into the 
corneas, and the difference between AMB and antimicrobial hydrogel was not significant. 
Representative sample of the cornea histopathologies are shown in Figure 4.21. 
 
As shown in Figure 4.21 B, no evidence of drug-related adverse effects in the uninfected 
eyes was observed. There was no significant difference between the treatment groups and 
control group with respect to inflammation, indicating the no clinically apparent toxicity 
of the treatments used. 
 
Figure 4.20 Typical clinical presentation of C. albicans keratitis mice eyes before and 
after treatment with control, Amphotericin B and gel 3. A. Keratitis before treatment; B. 




Figure 4.21 Representative example of histopathologies of treated and healthy corneas. 
Antibiofilm activity and selectivity were shown in A. Keratitis after being treated with 
control gel, AMB and cationic gel 3; Safety of the hydrogel was tested on health eye 
treated with control gel, AMB and cationic gel 3 (B). 
 
4.4 Conclusion 
In conclusion, we have designed and synthesized antimicrobial and antibiofilm 
stereocomplex hydrogel with distinctive supramolecular structures from the cationic 
polycarbonate polymers and PLA-PEG-PLA. We have demonstrated that the formation 
of the stereocomplex strongly enhanced its antimicrobial activities. These hydrogel 
possess a broad spectrum of superior antimicrobial activity with an inhibition above 
99.9% for various types of pathogens, including clinic isolated gram-positive, gram-
negative bacteria, fungi and yeast, yet induce relatively low cytotoxicity. Moreover, it 
was demonstrated that gel 1 and gel 2 has efficiently inhibited growth of fungi biofilm 
with low MIC values and clear fungal biofilm both in vitro. Compared to costly and 
unstable Amphotericin B, gel 1 and gel 2 are easy to prepare and can be stored for routine 
topical use with long shelf life. More importantly, preliminary keratitis treatment findings 
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suggest that topical solution of cationic hydrogel is safe and as efficacious as that of 
Amphotericin B, the most commonly used agent for the treatment of Candida keratitis. 
With an excellent biocompatibility, we believe that these hydrogel will be widely 
applicable for combating infections and provide a great platform for the applications in 




CHAPTER 5. CONCLUSION AND FUTURE PERSPECTIVES 
5.1 Conclusion 
The common theme, discussed and analyzed throughout the thesis, has been the design 
and optimization of well-defined hydrogel systems for different specific applications. 
Herein we described the synthesis, characterization and development of two different 
types of hydrogels for tissue engineering and antimicrobial therapeutics, respectively.  
 
In tissue engineering, a novel strategy, chemically incorporating micelles into the 
hydrogel system, has been proven to provide an alternative approach to tune the physical 
properties of the hydrogels as well as the subsequent cell behavior inside the hydrogels. 
In Aim (1), we have shown that the swelling ratio and porosity of the hydrogel increased 
with increasing micelle content from 0% to 80%. These hydrogels are biodegradable as 
demonstrated by a reduction in storage modulus over 28 days. Moreover, in Aim (2), 
subsequent cell matrix interactions showed that cell viability in the hydrogel with 20% 
micelle content was significantly higher the hydrogel without micelles. The same 
observation was seen for gene transfection efficiency in the hydrogel with 20% micelle 
content, which was significantly higher when compared to the control hydrogel without 
micelle. Our bolaamphiphile polymer was much more efficient as a gene carrier 
compared to the ‘golden standard’ of PEI. Thus we have successfully proven our 
hypothesis that incorporating micelle into the hydrogels is a good strategy to control 
cellular behavior in a 3D hydrogel environment for tissue engineering. 
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In antimicrobial therapeutics, a new hydrogel formulation with macromolecular cationic 
polymers encapsulated via stereocomplexation has been designed and evaluated. These 
hydrogels exhibited excellent antimicrobial and antibiofilm activities both in vitro and 
were shown to greatly improve fungal keratitis in vivo. In Aim (1), the screening of three 
cationic polymers with different cationic and hydrophobic length demonstrated that 
hydrophobic/hydrophilic balance is of great importance in the design of antimicrobial 
polymer without undesirable cytotoxicity. Diffraction peak in X-Ray diffraction study 
confirmed the hydrogel formation through stereocomplexation and rheology study 
showed shear-thinning property of the hydrogel. Furthermore, supramolecular structure 
was observed under SEM and TEM with a ribbon-like structure clearly seen. In Aim (2), 
hydrogels with different amounts of cationic polymer incorporated were tested against 
both S. aureus (G-positive), E. coli (G-negative) and C. albicans (fungus) and showed 
outstanding antimicrobial activities with killing efficiency near to 100%. SEM 
observation of the microorganisms in both control and treatment group revealed a 
membrane disruption mechanism by the polymers. These hydrogels were also tested 
against various clinically isolated drug-resistant pathogens including methicillin-resistant 
S. aureus (MRSA, Gram-positive), vancomycin-resistant enterococci (VRE, Gram-
positive), A. baumannii (Gram-negative, resistant to most antibiotics), K. pneumoniae 
(Gram-negative, resistant to carbapenem) and C. neoformans and found to yield 99.99% 
of killing efficiency. Our study on antibiofilm has shown that these hydrogels were 
capable of dispersing biofilms formed from S. aureus (G-positive), MRSA, E. coli (G-
negative) and C. albicans (fungus) with the majority of the biofilm removed and cells 
lysed. In Aim (3), these hydrogels were applied on a fungal keratitis model and showed 
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comparable treatment effect with the commercially available antibiotic Amphotericin B, 
in both reducing fungi recovery and hyphae invasion yet induced no toxicity on the 
healthy eyes. Thus we successfully proved our hypothesis that incorporating cationic 
polymer into hydrogel system served as an effective platform to treat microorganisms and 
biofilms infections both in vitro and in vivo. 
 
5.2 Future perspectives 
This work has contributed not only to the development of new strategies for hydrogel 
applications in tissue engineering and antimicrobial therapeutics, but also identified 
potential opportunities in interdisciplinary subject of hydrogel for biomedical 
applications that can be further investigated.  
 
Firstly, through our preliminary study performed in Chapter 3, we have confirmed that in 
addition to the many strategies that have been previously studied to improve PEG 
hydrogels for tissue engineering, incorporating nanostructured micelle into PEG 
hydrogels is a novel and feasible method to tune the physical properties of hydrogel, thus 
these hydrogels serve as an excellent platform for cell and gene delivery. Growth factor 
delivery for tissue engineering has been widely reported in the literature, for example, 
transforming growth factor beta (TGF-ß) superfamily including TGFß1, TGFß2 and 
TGFß3 have been widely studied in inducing chondrogenesis of MSCs under certain 
culture conditions [216, 217], Chung et al have significantly improved bone regeneration 
with the addition of recombinant bone morphogenetic protein-2 (BMP-2) [218]. However, 
delivery of therapeutic gene coded for these growth factors provided even greater 
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guidance in differentiation [219]. Herein, we propose that further investigations can be 
pursued with a wide coverage of therapeutic gene delivery coded for these growth factors 
to determine whether nanostructured PEG hydrogel is indeed a broadly applicable 
formulation for cell and gene delivery in tissue engineering. 
 
Secondly, the success of tissue engineering is greatly dependent on the scaffold design. 
Consequently, more synthetic material development will have a significant impact on 
tissue engineering. For instance, environmentally responsive materials and the 
subsequently developed cell-responsive hydrogels will be an interesting scaffold to 
investigate. In addition, development in biological science, including understanding of 
more novel specific cell ligands, cell-cell interaction within the scaffold and cell-matrix, 
are of great importance in improving communications between natural tissues and 
artificial scaffolds. Last but not least, due to the potentially extensive applicability of the 
hydrogel system in biomedical area, it is essential to develop new well-defined hydrogels 
with their specific end-application in mind. As different applications require specific 
physical and biochemical properties of the hydrogel scaffold, such as stiffness, 
degradation rate and bioactive cues, this aspect should be taken into consideration in the 
future studies to fine tune hydrogel properties for specific tissue engineering studies both 
in vitro and in vivo.   
 
Although currently increasing antimicrobial polymers has been synthesized and identified, 
in order to establish and explore the full potential of novel synthetic polymers as major 
treatments for infectious disease, several issues need to be carefully addressed. Firstly, it 
102 
is crucial to fine tune the structural parameter of the polymers, including cationic charge 
density, hydrophobicity and defined architecture (branched or linear), to obtain optimal 
antimicrobial activity and selectivity. As biocompatibility is another important aspect of 
polymer used in clinic settings, designing antimicrobial polymers with desired 
degradation rate and non-toxic degradation products deserves equal attention in research 
studies. Secondly, successful development of fast and reliable evaluation method of 
antimicrobial activity is a weapon for screening synthetic polymers. Currently, there are 
quite a few uncertainties in the universal utilization of broth microdilution method to 
determine MIC value of antimicrobial agents. These factors include the nature of 
microorganism in size, shape and growth curve, growth media and incubation time in 
culturing different microorganisms and even test condition difference employed by 
various research laboratories. Thus there is a pressing need to establish and validate 
standardized test for antimicrobial screening and ensuring rapid clinical translation is 
another important aspect to be taken into consideration. 
 
Despite the huge potential of these polymers shown in vitro, there is still a long way to go 
in order to evaluate their safety and efficiency in vivo. Therefore, more effort needs to be 
devoted to develop proper infectious animal disease model and clinical trials for 
evaluation of molecular distribution, efficiency and toxicity of these polymers. These 
models can closely mimic the pathological environments in human body and provide 
accurate prediction in using novel antimicrobial polymers. Furthermore, the exact 
mechanism of antimicrobial activity of these polymers remains unclear, more research 
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need to be done to explore the mechanism behind and hopefully shed light on the 
development of antimicrobial polymers for targeted microorganisms. 
 
In hydrogel for antimicrobial applications, although potential and advantages of 
hydrogels with cationic polycarbonate polymer incorporated has been shown in Chapter 4, 
it is critical to evaluate how formulating polymers interact with and affect the efficiency 
of incorporated therapeutics such as antibiotics, AMP and polymers in the scaffold. This 
can be done by monitoring MIC level of antibiotics in the presence/absence of scaffold 
exponents. Moreover, currently no hydrogel system has been tested to be used in clinic 
due to compatibility of the polymer systems. Thus in vivo studies are urgently needed to 
test the hydrogel stability and more importantly, toxicity. 
 
In conclusion, finding of this thesis have effectively supported that PEG hydrogel 
scaffolds can be rationally designed for both tissue engineering and antimicrobial 
therapeutics. Pending proper material designing, advanced development of biological 
science and successful modification of the hydrogel scaffolds may intensely facilitate the 
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Appendix A: Synthetic procedures and molecular characterization of VS-PEG-CPC 
and cationic bolaamphiphile 
 
A.1 Materials and methods 
Materials 
All reagents were purchased from Sigma-Aldrich and used as received unless otherwise 
noted. Tetra acrylate PEG (Mn 10,000 g/mol) and tetra sulfhydryl PEG (Mn 10,000 
g/mol) were purchased from Sunbio Corporation (South Korea). SH-PEG-OH (Mn 5000 
g/mol, PDI 1.03) was purchased from RAPP Polymere GmbH (Germany). Sparteine was 
stirred over CaH2, distilled in vacuum twice, and then stored in glove box. N-(3,5-
trifluoromethyl)phenyl-N’-cyclohexylthiourea (TU) was prepared according to our 
previous protocol [154]. TU was dissolved in dry THF, stirred with CaH2, filtered, and 
freed of solvent in vacuo. 
 
Synthesis of VS-PEG-PC polymer   
The functional carbonate monomers, MTC-OEt and MTC-urea, were prepared according 
to the protocol reported in the previous work [154, 220]. 
 
Synthesis of VS-PEG-OH 
In a nitrogen gas atmosphere, triethylamine (23 L, 0.16 mmol) was added to a solution 
of HS-PEG-OH (0.2 g, 0.04 mmol) in MeOH (5 mL). And then, the resulted solution was 
118 
to dryness. Finally, the crude product was purified by column chromatography added 
dropwise to a solution of divinyl sulfone (124 L, 1.2 mmol) in MeOH (5 mL) under 
stirring. The reaction mixture was heated to 60 C and reacted for 6 hours before 
concentrated on a Sephadex LH-20 column with THF as eluent, giving VS-PEG-OH as 
white powder (0.2 g, 100%). 1H-NMR (400 MHz, DMSO-d6, 22 °C) δ 6.6  (q, 1H, H of 
methine), 6.46 (d, 1H, H of methylene), 6.19 (d, 1H, H of methylene), 3.63 (s, 455H, H 
of PEG), 3.25 (m, 2H, -SCH2CH2O-), 2.86 (m, 4H, -CH2CH2SCH2CH2O-), 2.48 (m, 
2H, -SO2CH2CH2S-).   
 
Synthesis of VS-PEG-P[(MTC-OEt)-random-(MTC-urea)] (Scheme A.1) 
In a glove box, a solution of VS-PEG-OH (0.26 g, 0.05 mmol) in CH2Cl2 (0.75 mL) was 
mixed with the solution of TU (18.5 mg, 0.05 mmol) in CH2Cl2 (0.75 mL), followed by 
adding sparteine (11.5 L, 0.05 mmol), and the formed solution kept stirring for 10 min. 
Then, a solution of MTC-OEt (0.094 g, 0.5 mmol) and MTC-urea (0.081 g, 0.25 mmol) 
in CH2Cl2 (1.5 mL) was added  to the reaction mixture and reacted for 16 hours before 
benzoic acid (15-20 mg) was added to quench the polymerization. The reaction mixture 
was purified by column chromatography on a Sephadex LH-20 column with THF as 
eluent, to give HS-PEG-P[(MTC-OEt)8-random-(MTC-urea)4] as off-white sticky solid 
(0.35 g, 86%).1H-NMR (400 MHz, DMSO-d6, 22 °C) δ 7.43 (s, 8H, PhH), 7.24 (s, 8H, 
PhH), 6.98 (s, 4H, PhH), 6.70 (q, 1H, H of methine), 6.47 (d, 1H, H of methylene), 6.21 
(d, 1H, H of methylene), 4.17-4.32 (m, br, 72H, -CH2OCOO- and -COOCH2-), 3.69 (s, 
455H, H of PEG), 3.45 (s, br, 8H, -CH2NHCO-), 3.24 (m, 2H, -SCH2CH2O-), 2.87 (m, 
4H, -CH2CH2SCH2CH2O-), 2.48 (m, 2H, -SO2CH2CH2S-), 1.22 (s, 60H, -CH3).   
119 
 
Gel permeation chromatograph (GPC)  
GPC analysis for block copolymers was carried out with a Waters HPLC system 
equipped with a 2690D separation module with two Styragel HR1 and HR4E (THF) 5 
mm columns (size: 300 × 7.8 mm) in series and a Waters 410 differential refractometer 
detector. THF was used as the mobile phase with a flow rate of 1 mL/min. A calibration 
curve was constructed using a series of polystyrene standards (molecular weight: 1,350-




H NMR spectroscopy  
1
H NMR analyses of monomers and block copolymers were performed on a Bruker 
Advance 400 NMR spectrometer at 400 MHz at room temperature (25 ± 2C). The 1H 
NMR measurement parameters: acquisition time of 3.2 s, pulse repetition time of 2.0 s, 
30° pulse width, 5208-Hz spectral width, and 32 K data points. Chemical shifts were 
referred to the solvent peaks (δ = 7.26 and 2.50 ppm for CDCl3 and DMSO-d6, 
respectively).  
 
A.2 Results and discussion 
Synthesis of VS-PEG-PC polymer 
Vinyl sulfone-functionalized PEG-b-polycarbonate (VS-PEG-PC) containing ethyl and 
urea functional pendant groups were synthesized by ROP of two monomers derived from 
2,2-bis(methylol)propionic acid bearing pendant functional ethyloxycarbonyl groups 
120 
(MTC-OEt) or pendant funcational urea groups (MTC-urea) using vinyl sulfone-
terminated PEG (VS-PEG-OH) as a macroinitiator (Scheme A.1). VS-PEG-OH was 
obtained from reacting HS-PEG-OH (Mw 5,000 g/mol) with a large excess amount of 
divinyl sulfone (molar reatio of HS-PEG-OH:divinyl sulfone is 1:30), and then the excess 
divinyl sulfone was removed by column chromatography on a Sephadex LH-20 column 
using methanol as eluent. In the polymerization reaction, parteine and TU, instead of 1,8-
diazabicyclo[5.4.0]undec-7-ene (DBU), are used as catalysts because DBU can cause 
precipitation of MTC-urea monomer. The polymer with vinly sulfone group was obtained 
in high yield and narrow molecular weight distribution (PDI 1.12, shown in Figure A.1). 
The composition of VS-PEG-polycarbonate polymer was estimated from 
1
H NMR 
spectrum (Figure A.2). All peaks attributed to vinyl sulfone group, PEG, MTC-OEt and 
MTC-urea were clearly observed in the proton spectrum. Quantitative comparisons 
between the integral intensities of the peak of ethylene groups of PEG, phenyl hydrogen 
of MTC-urea and methyl groups of MTC-OEt and MTC-urea gave the composition of the 
polymer, and there were 8 MTC-OEt units and 4 MTC-urea units in the VS-PEG-
polycarbonate polymers as shown in Scheme 1. In addition, the polymer molecular 
weight estimated from 
1
H NMR spectroscopy (Figure A.2) was consistent with that 
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Figure A.1 GPC diagram of VS-PEG-PC (Mn = 10,120, Mw/Mn = 1.12). 
 
Figure A.2 Characterization of VS-PEG-OH, VS-PEG-polycarbonate (VS-PEG-PC) and 
its self-assemblies: 1H NMR spectra of (A) VS-PEG-OH and (B) VS-PEG-PC in CDCl3. 
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Appendix B: Synthetic procedures and molecular characterization of cationic 
bolaamphiphile 
 
Synthesis of cationic bolaamphiphile 
The detailed synthesis and characterization for the cationic bolaamphiphile (Scheme 3.3) 
has been shown elsewhere [153]. This bolaamphiphile was synthesized using a three-step, 
two-pot procedure where pentaethylenehexamine was used as the hydrophilic amine unit, 
whilst 1,12-diaminododecane was used as the hydrophobic unit. In brief, the hydrophobic 
component of the bolaamphiphile was prepared by reacting 1,12-diaminododecane with a 
thiol ester, methyl-3-mercaptopropoinate, via nucleophilic substitution in a one-pot 
procedure at 80 ºC for 24 hours in order to form the bolaamphiphile precursor molecule.  
Next using a ring-opening mechanism the precursor molecule was reacted with 
epichlorohydrin (glycidyl) to form the linker unit that was further connected to the 
hydrophilic pentaethylenehexamine unit via nucleophilic substitution to give rise to the 
final cationic bolaamphiphile. Successful synthesis of the precursor molecule and 
cationic bolaamphiphile were evidenced primarily by their IR spectra in conjunction with 
1H NMR and 13C spectra. The 1H NMR spectrum of the cationic bolaamphiphile 
showed the presence of the hydrophobic diaminododecame as indicated by a broad set of 
peaks in the range of δ = 1.6-1.00 ppm. In addition, a peak at δ = 3.70 ppm was observed, 
which was assigned to the distinct methine proton (-CH2-CH(OH)CH2-) of the glycidyl 
linker unit.  The presence of this peak proved the hydrophilic pentaethylenehexamine unit 
was connected to the hydrophobic diaminododecane unit via the glycidyl linker unit. 
Lastly, various sets of peaks were seen in the range of δ = 3.30-2.30 ppm, which were 
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mainly assigned to the methylene protons of the bolaaphiphile molecule. Bolaamphiphile: 
max/cm-1 3360 strong (sharp) [(N-H)]; 3310 strong (sharp) [(N-H)]; 2960 medium 
(sharp) [(C-H)]; 2830 medium (sharp) [(C-H)]; 1660 strong (sharp) [(C=O)]; 1120 
weak (sharp) [(C-OH)]. H (400 MHz, D2O) 3.70 (1H, m, -CH2-CH(OH)CH2-); 3.30-
2.20 (2H, t, NH2-CH2-CH2-NH-, -CH2-CH2-CH2-NH-C(=O)-CH2-CH2-S-, -CH2-
CH(OH)CH2-) and 1.60-1.00 ppm (-(O=)C-NH-CH2-(CH2)10-CH2-NH-C(=O)-).  
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Appendix C: Synthetic procedures and molecular characterization of P(D/L)LA-
PEG-P(D/L)LA and cationic polymer PDLA-CPC-PDLA  
Materials 
L-lactide and D-lactide were obtained from Purac Biochem Gorinchem NL and 
recrystallized three times from toluene and dried in vacuum prior to use. Diol functional 
poly(ethylene glycol) macro-initiators were dried by azeotropic distillation with toluene 
and dried at 50 °C under reduced pressure. Dry toluene and dichloromethane (DCM) 
were obtained from a drying column using a setup from Innovative Systems Inc., with a 
60 Å 230-400 Mesh ASTM Silicon Gel Whatman column. (-)-Sparteine (Sigma-Aldrich, 
99%) and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU, Sigma-Aldrich, 98%) were distilled 
over calcium hydride. 1-(3,5-Bis(trifluoromethyl)phenyl)-3-cyclohexcylthiourea (TU), 
benzyl bis(2,2-hydroxymethyl)propionate (BnMPA), 2-(3-chloropropyl)oxycarbonyl-2-
methyl trimethylene carbonate (MTC-CP), and 2-(3-bromopropyl)oxycarbonyl-2-methyl 
trimethylene carbonate (MTC-BP) were synthesized as previously reported elsewhere 
[221, 222]. All other chemicals and solvents were purchased from Sigma-Aldrich and 






C-NMR spectra were acquired on a Bruker Avance 400 instrument operated at 
400 and 100 MHz, respectively. Gel Permeation Chromatography (GPC) in THF was 
performed at 30 ºC using a Waters chromatograph equipped with four 5 μm Waters 
columns (300 mm × 7.8 mm) connected in series (HR1, HR2, HR4E and HR5E), a 
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Waters 2410 refractive index (RI) detector and a 996 photodiode array detector, and 
calibrated with polystyrene standards (560 to 2 × 10
6
 g/mol).  
 
Synthesis of PLA-PEG-PLA triblock copolymers (Scheme C.1).  
These triblock copolymers were prepared via organocatalytic ring-opening 
polymerization (ROP). Diol functional poly(ethylene glycol) (PEG) having a number 
average molecular weight (Mn) of 6000 g/mol (PEG1) or 8000 g/mol (PEG2) was used 
as an initiator for the ROP of either L-lactide or D-lactide using a mixture of 1-(3,5- 
bis(trifluoromethyl)-phenyl)-3-cyclohexylthiourea (TU) and (-)-sparteine as catalysts in 
methylene chloride. As an example, PEG2 (Mn = 8K, 0.40 g, 0.05 mmol) was dissolved 
in 2 ml of methylene chloride. In a separate vial, L-lactide (0.20 g, 1.38 mmol) was 
charged along with catalysts TU (0.025 g, 0.007 mol) and (-)-sparteine (0.016 g, 0.007 
mol), and dissolved in methylene chloride. The L-lactide solution was added to the PEG2 
initiator solution and the polymerization was followed for 6 hours by 
1
H NMR, at which 
time the L-lactide consumption was complete. The product was precipitated in ether, 
isolated by filtration, and dried. The non-charged triblock copolymer was characterized 
by 
1
H NMR and GPC. 
 
Scheme C.1 Typical synthesis of polylactide-b-poly(ethylene glycol)-b-polylactide 
(PLA-PEG-PLA) triblock copolymer.  
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Synthesis of PDLA-CPC-PDLA triblock copolymers (Scheme C.2) 
 
Synthesis of precursor polymers 
The precursor triblock copolymers were prepared by sequential ROPs of a MTC-PrCl or 
MTC-PrBr monomer to form the precursor core block, followed by polymerization of D-
lactide to form the peripheral hydrophobic blocks. The initiator was a diol, BnMPA. The 
polymerization was catalyzed by TU and DBU in methylene chloride at room 
temperature (25 ± 2C, 1 to 2 hours). Typically, MTC-PrCl (365 mg, 1.54 mmol), 
BnMPA (22.2 mg, 0.10 mmol), and TU (14.5 mg, 0.039 mmol) were dissolved in 
methylene chloride (1.0 mL), and this solution was transferred to a vial containing DBU 
(6.0 mg, 0.039 mmol) to start polymerization at room temperature (DP1 = 16). After 5 
hours (conversion of MTC-PrCl ~93%), the solution was transferred to a vial containing 
D-lactide (DLA) (261 mg, 1.81 mmol) to start the second polymerization. The second 
polymerization was stirred for 19 hours at room temperature (DP2 = 18). Conversion of 
DLA was about 95%. Acetic anhydride (57 mg, 0.56 mmol) was added to the reaction 
mixture, and stirring was continued 96 hours, thereby forming an acetyl end-capped 
precursor triblock copolymer, Precursor I. The end-capped block copolymer was 
precipitated in cold methanol, centrifuged, and dried in vacuum. Yield of Precursor I: 497 
mg (77%), GPC (THF): Mn 12700 g/mol, PDI 1.15, 
1
H NMR (400 MHz, CDCl3):  7.39-
7.28 (m, ArH), 5.23- 5.05 (m, PhCH2, CHPDLA), 4.40-4.17 (m, CH2OCOOpoly(MTC-PrCl), 
OCH2 poly(MTC-PrCl)), 3.65-3.53 (m, CH2Clpoly(MTC-PrCl)), 2.17-2.03 (m, CH2 poly(MTC-PrCl), 
OCH3 end group), 1.64-1.46 (m, CH3 PDLA), 1.31-1.19 (m, CH3 poly(MTC-PrCl)). 
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Precursor II was prepared by the same protocol as that of Precursor I using MTC-PrBr 
(325 mg, 1.15 mmol) in place of MTC-PrCl, BnMPA (14.5 mg, 0.065 mmol), TU (11.9 
mg, 0.032 mmol), DBU (5.1 mg, 0.033 mmol) and DLA (146 mg, 1.01 mmol) to yield 
the polymer with DP1 = 18 and DP2 = 16. Yield: 307 mg (63%), GPC (THF): Mn 4400 
g/mol, PDI 1.08, 
1
H NMR (400 MHz, CDCl3):  7.40-7.28 (m, ArH), 5.26-5.04 (m, 
PhCH2, CHPDLA), 4.41-4.16 (m, CH2OCOO poly(MTC-PrBr), OCH2 poly(MTC-PrBr)), 3.53-3.37 (m, 
CH2Br poly(MTC-PrBr)), 2.25-2.14 (m, CH2 poly(MTC-PrBr)), 2.13 (s, OCH3 end group), 1.64-1.46 (m, 
CH3 PDLA), 1.33-1.19 (m, CH3 poly(MTC-PrBr)). 
 
Quaternization with trimethylamine.  
Trimethylamine gas (782 mg, 13.2 mmol) was charged to an acetonitrile solution (4 mL) 
of Precursor I (466 mg, [Cl] = 0.98 mmol) immersed in a dry-ice/acetone bath. The 
solution was then allowed to warm up to 50° C and kept stirring for 14 hours before 
acetonitrile and excess gasses were removed under vacuum. The concentrated residue 
was dried in vacuum (~88% quaternized). Yield of PDLA-CPC-PDLA 1: 461 mg (88%), 
GPC (DMF): Mn 8900 g/mol, PDI 1.17, 
1
H NMR (400 MHz, MeOH-d4):  7.44- 7.31 (m, 
ArH), 5.27-5.03 (m, PhCH2, CHPDLA), 4.48-4.18 (m, CH2OCOOPC, OCH2 PC, OCH2 PC), 
3.59-3.41 (br, N
+
CH2 PC), 3.25-3.13 (br, N
+
CH3 PC), 2.29-2.16 (br, CH2 PC), 2.09 (s, OCH3 
end group), 1.60-1.40 (m, CH3 PDLA), 1.35-1.24 (m, CH3 PC). 
 
PDLA-CPC-PDLA 2 (~89% quaternized) was prepared by the same procedure using 
Precursor II. Yield: 471 mg (81%), GPC (DMF): Mn 9400 g/mol, PDI 1.15. 
1
H NMR 
(400 MHz, MeOH-d4):  7.42-7.34 (m, ArH), 5.26-5.04 (m, PhCH2, CHPDLA), 4.45-4.20 
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(m, CH2OCOOPC, OCH2 PC, OCH2 PC), 3.63-3.43 (br, N
+
CH2 PC), 3.28-3.13 (br, N
+
CH3 PC), 
2.31-2.15 (br, CH2 PC), 2.09 (s, OCH3 end group), 1.62-1.40 (m, CH3 PDLA)), 1.36-1.24 (m, 
CH3 PC). 
 
Scheme C.2 Typical preparation of poly(D-lactide)-b-cationic poly(carbonate)-b-poly(D-
lactide) (PDLA-CPC-PDLA) triblock copolymers.  
 
 
